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ABSTRACT  
 
INVESTIGATIONS OF CEREBRAL HEMODYNAMICS IN INFANTS WITH 
CRITICAL CONGENITAL HEART DISEASE USING DIFFUSE OPTICS 
Jennifer M. Lynch 
Arjun G. Yodh 
Congenital heart defects (CHD) are the most common type of birth defect, 
affecting approximately 30,000 children each year, one third of whom require cardiac 
surgery in their first year of life.  Surgical advances have improved the cardiac outcomes 
for these children, and since the majority of these patients now reach school age, the 
research focus has shifted to address neurodevelopmental difficulties of survivors.  A key 
physiological factor appears to be the high prevalence of hypoxic-ischemic white mater 
brain injury observed in these children. The exact timing of the injury occurrence, 
however, is difficult to ascertain due to limitations of the imaging modalities employed 
for this fragile, infant population.  
This thesis develops and explores the use of diffuse optical spectroscopy 
techniques for investigation of the risk factors for hypoxic-ischemic brain injury in these 
infants. The optical techniques utilize near-infrared (NIR) light and the diffusion 
approximation to model light transport in order to probe the static and dynamic properties 
of tissue.  Frequency-domain diffuse optical spectroscopy (FD-DOS) is a technology, 
similar to widely used near-infrared spectroscopy (NIRS), that permits quantification of 
tissue oxygen saturation and total hemoglobin concentration.  Diffuse correlation 
spectroscopy (DCS) is a relatively newer technique, centered on an idea similar to 
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dynamic light scattering, which enables quantification of blood flow. Both FD-DOS and 
DCS are used in this research. 
 The experiments presented in this thesis explore a variety of biophysics and 
biomedical questions. Arguably, the most important clinical findings to emerge from this 
dissertation are new risk factors associated with brain injury in infants with a certain form 
of CHD called hypoplastic left heart syndrome (HLHS).  Using the aforementioned 
optical techniques, we found that longer time-to-surgery, lower cerebral oxygen 
saturation, and higher cerebral blood flow measured on the morning of surgery were 
associated with the risk of acquiring post-operative brain injury in this cohort.  The 
results are novel for the community and shift our understanding of when these neonates 
are most at risk for acquiring brain injury.  Most importantly, these results and the 
technology developed should improve current clinical care of this patient population. 
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1 Introduction 
1.1 Critical Congenital Heart Disease 
Congenital heart defects (CHD) are among the most common birth defects in 
humans.  CHD affect 1 out of every 120 babies in the United States and over 1 million 
babies worldwide.  Complex congenital heart defects account for approximately a third of 
these cases.  Infants born with these complex defects require cardiac surgery in their first 
few months of life [1].  Two common complex congenital heart defects that are the focus 
of the work presented in this thesis are transposition of the great arteries and hypoplastic 
left heart syndrome.  These specific defects are described in detail in Section 6.1. 
1.2 Associated Neurodevelopmental Outcomes 
Surgical advances over the last 20 years have significantly improved survival and 
cardiac outcomes in infants with critical CHD.  Now that more of these children are 
reaching school age, neurodevelopmental dysfunction has been reported to occur in 
approximately half of all survivors [2].  These school-age survivors are at higher risk for 
inattention and hyperactivity, impaired cognitive and fine motor skills, learning and 
speech disabilities, and lower IQs [3-6].  Thus, the focus of research has now shifted to 
improvement of the neurocognitive outcomes in this population.  
1.3 Periventricular Leukomalacia 
The underlying cause of the high prevalence of neurobehavioral symptoms seen 
in children with CHD is believed to be the high prevalence of a specific form of brain 
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injury called periventricular leukomalacia (PVL) [7].  PVL is a specific form of hypoxic-
ischemic white matter injury that commonly occurs in a vascular watershed zone near the 
lateral ventricles.  This region of white matter is highly susceptible to hypoxic-ischemic 
injury during early brain development due to the maturation stage of the oligodendrocytes 
[8].  PVL is most often observed in preterm neonates, who have neurodevelopmental 
outcomes remarkably similar to those of term patients with CHD.  This injury is observed 
in magnetic resonance imaging (MRI) scans as T1-hyperintense lesions, further enabling 
quantification of injury severity [7, 9, 10].  However, the exact timing of this injury 
remains unknown. 
1.4 Imaging and Monitoring of the Infant Brain 
To elucidate the timing and cause of PVL, a monitor of cerebral oxygenation and 
blood flow during periods of highest risk is imperative.  Although various techniques are 
available and have been used for imaging and monitoring the infant brain, all of these 
techniques have associated disadvantages.  A complete summary of these techniques and 
their advantages and disadvantages has been reported [11, 12].  
Current established tools for measuring cerebral blood flow (CBF) include 
various forms of MRI, transcranial Doppler ultrasound (TCD), positron emission 
tomography (PET) and Xenon enhanced computer tomography (Xenon-CT).  A major 
disadvantage of most of these techniques is that they can only be used as spot 
measurements of CBF, i.e., they cannot be employed for continuous monitoring.  This 
situation presents a significant limitation for investigation of periods of risk for infants 
with CHD, because they may be susceptible to PVL during long pre-operative, operative 
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and post-operative time periods.  While TCD can be used for non-invasive monitoring of 
cerebral hemodynamics, assumptions about the cerebral vessel diameters can cause large 
errors in measurements of cerebral blood flow velocity.  TCD is also unable to measure 
regional variations in cerebral blood flow. Additionally, PET and Xe-133 expose the 
patient to radiation, which can be particularly harmful to neonates.   
1.5 Novel Role of Diffuse Optical Spectroscopies 
Thus there exists an unfilled niche for a non-ionizing, non-invasive, continuous 
monitor of cerebral hemodynamics for neonates.  Diffuse optical spectroscopy (DOS) and 
diffuse correlation spectroscopy (DCS) are optical techniques based on the diffusion 
approximation for light transport that enable quantification of cerebral oxygenation, total 
hemoglobin concentration, and blood flow.  These optical techniques are non-invasive, 
utilize non-ionizing radiation, and can be deployed at the bedside.  Since they can be 
performed at the patient’s bedside, they permit continuous monitoring of cerebral 
hemodynamic parameters, a capability that most other modalities fail to provide.  I 
describe these techniques in further detail in Sections 2 and 4. 
 
1.6 Summary and Thesis Organization 
Neonates with critical CHD experience a high risk for neurobehavioral symptoms 
later in life and an associated hypoxic-ischemic white matter injury termed PVL.   And, 
as noted above, diffuse optical spectroscopies provide a novel tool for monitoring 
cerebral oxygenation and blood flow in these neonates that enables elucidation of the 
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exact timing and cause of this brain injury.  I will describe my research on this problem 
and related studies of hemodynamics in the baby brain. 
In Chapter 2 of this thesis, I describe the instrumental and theoretical ideas that 
underpin DOS.  In Chapter 3, I explain research that I have done further developing and 
validating a novel that utilizes frequency-filtered DOS for determination of cerebral 
venous oxygenation. This work has led to a publication [13]. 
In Chapter 4, I describe the physics associated with DCS, and I describe the DCS 
instrument that I assembled and used for the results presented here.  I also describe work 
that I have done in validating this technique in-vivo, which has also been published [14].  
Finally, I demonstrate an important new clinical use for DCS, i.e., I describe a clinical 
study that I conducted wherein I employ DCS to measure changes in cerebral blood flow 
due to clinically administered adenosine.  This work is currently in preparation for 
publication and has been presented at an international conference [15]. 
In Chapter 5, I describe the combined use of DOS and DCS for measuring 
cerebral oxygen metabolism.  I first discuss the hybrid instrument that I assembled. I then 
describe work that I did in validating measurements of cerebral oxygen metabolism, 
which has led to a publication [14]. Finally, I describe work demonstrating the clinical 
usefulness of hybrid DOS/DCS measurements in a clinical study measuring cerebral 
oxygen metabolism in children with pulmonary hypertension. 
Finally, in Chapter 6, I describe an investigation on a cohort of infants with CHD 
that I have been studying for the past 4 years. I summarize what we have learned through 
the use of diffuse optics about the underlying cause for brain injury seen in this cohort.  I 
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will specifically highlight my major clinical result, which has led to a publication [16] on 
predictive risk factors for brain injury in certain forms of CHD.  
  
 6 
2 Diffuse Optical Spectroscopy 
Diffuse optical spectroscopy (DOS), also known as Near-Infrared Spectroscopy 
(NIRS), utilizes near-infrared light to noninvasively probe the optical properties of tissue, 
namely tissue absorption and scattering.  The primary NIR-light-absorbing chromophores 
in brain tissue are oxy-hemoglobin (HbO2), deoxy-hemoglobin, (Hb) and water (H2O).  
Thus, by quantifying the light absorption of tissue, one can derive and elucidate clinically 
meaningful physiological parameters from the concentrations of these chromophores. 
 
Figure 1: A sample absorption spectrum of the main chromophores of tissue: HbO2 (red), 
Hb (blue), and H2O (black).  The zoomed-in region depicts the NIR region of light in 
which scattering, not absorption, dominates for biological tissue, allowing for photons to 
deeply penetrate. 
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To understand why wavelengths in the near-infrared (NIR) are well-suited for 
DOS, Figure 1 shows an example of the absorption spectra of the main chromophores in 
brain tissue.  This plot shows the wavelength-dependent absorption coefficient, µa(λ), in 
units of cm-1, as a function of wavelength (λ) for the three main chromophores in brain 
tissue. The absorption coefficient of a tissue chromophore, µa(λ), is the inverse of the 
mean distance that a photon of wavelength λ travels in tissue containing that 
chromophore before it has an e-1 probability of having been absorbed.  Inside the NIR 
region, the absorption of light is low, permitting deep penetration of photons.  
Additionally in this region, the spectral dependence of the absorption of light due to the 
three main chromophores is distinct, thereby permitting separation of the effects of each 
chromophore (Figure 1).  
In order to quantify the amount of light that is absorbed by different components 
of the tissue and thus quantify µa(λ), one needs to separate out the light scattering 
property of tissue from the light absorbing property of tissue.  The wavelength-dependent 
scattering coefficient, µs(λ), is the inverse of the mean distance that a photon of 
wavelength λ travels in tissue before it has an e-1 probability of having been scattered.  
The following section will discuss how one separates the effects of these two optical 
properties.  Later in this chapter, I will describe the instrumentation employed to carry 
out these measurements and, finally, the physiological parameters that can be extracted. 
2.1 Photon Diffusion in Tissue 
NIR light propagation through tissue can be approximated as a diffusive process, 
with each photon traveling along a random walk trajectory.  Mathematical modeling of 
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the transport of photon energy in tissue typically begins with the radiative transfer 
equation (RTE) [17] 
!! !"(!,!,!)!" + ∇ ∙ 𝐿 𝑟, s, 𝑡 s = −𝜇!𝐿 𝑟, s, 𝑡 + 𝜇! 𝐿 𝑟, s, 𝑡 𝑓 s′, s 𝑑s′+ 𝑆(𝑟, s, 𝑡). ((2.1) 
Here the radiance, 𝐿 𝑟, s, 𝑡 , is described using conservation of energy and is defined as 
the power of light per unit area traveling in direction s around position 𝑟 at time 𝑡 with 
units W/(cm2∙sr); 𝑣 is the speed of light in the medium; 𝜇! is the total transport 
coefficient defined as 𝜇! =𝜇! +𝜇!; 𝑓 s′, s  is essentially the probability of light scattering 
in a single event from the s′ direction into the s direction; and 𝑆(𝑟, s, 𝑡) is the term 
representing the light source.  This equation assumes that the scattering and absorption 
lengths are much larger than the wavelength of the light, that the light is unpolarized, and 
that 𝑣 is spatially homogeneous throughout the medium. The diffusion approximation of 
light transport describes the photon fluence rate, Φ 𝑟, 𝑡 ,  and the photon current density, J 𝑟, 𝑡 , which are related to light radiance as follows: 
 Φ(𝑟, 𝑡) = 𝐿 𝑟, s, 𝑡 𝑑s; ((2.2) 
 J(𝑟, 𝑡) = 𝐿 𝑟, s, 𝑡 s𝑑s. (
(2.3) 
 The RTE is simplified by expanding terms using spherical harmonics:  
 𝐿 𝑟, s, 𝑡 ≈ Φ!,!(𝑟, 𝑡)𝑌!,!(s)!!!!!!!!! ; ((2.4) 
 𝑆 𝑟, s, 𝑡 = q!,!(𝑟, 𝑡)𝑌!,!(s)!!!!!!!!! . ((2.5) 
For nearly isotropic radiance, a 𝑃!  approximation can be performed to leave only the 𝑙 = 0 and 𝑙 = 1 terms [18, 19], and then it is readily shown that 
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 𝐿 𝑟, s, 𝑡 = !!!Φ 𝑟, 𝑡 + !!! 𝐽 𝑟, 𝑡 ∙ 𝑠. ((2.6) 
Thus with this approximation of an isotropic source and an additional assumption of 
isotropic scattering (i.e., 𝑓 s′, s = 𝑓 s′ ⋅ s ), the RTE can be simplified to the photon 
diffusion equation: 
 ∇ ∙ 𝐷(𝑟 ∇  Φ 𝑟, 𝑡 − 𝑣𝜇! 𝑟 Φ 𝑟, 𝑡 + 𝑣𝑆 𝑟, 𝑡 = !! !,!!" . ((2.7) 
Here, 𝐷 𝑟  is the photon diffusion coefficient in units of cm2/s and is defined as:   
 𝐷 𝑟 = !!(!!! ! !!! ! ) ≅ !!(!!! ! ). ((2.8) 
The reduced scattering coefficient, 𝜇!′ is related to the scattering coefficient by 𝜇!′ 𝑟 = 𝜇!(1− 𝑔), where 𝑔 is defined as the average cosine angle of a scattering event, 
 𝑔 = 𝑓 𝑠 ∙ 𝑠′ 𝑠 ∙ 𝑠′𝑑𝑠′ = 𝑐𝑜𝑠𝜃 . (
(2.9) 
Thus, 𝜇!′ is approximately the mean inverse distance a photon travels before its direction 
has an e-1 probability of becoming randomized (i.e., the inverse distance of 𝜇!′ is the 
photon random walk step). 
 The photon diffusion equation can be further simplified by assuming that tissue is 
a homogeneous medium, i.e., 𝐷 𝑟 = 𝐷, 𝜇!′ 𝑟 = 𝜇!′ and 𝜇! 𝑟 = 𝜇!.  The resulting 
simplified equation is: 
 𝐷∇!  Φ 𝑟 − 𝑣𝜇!Φ 𝑟, 𝑡 + 𝑣𝑆 𝑟, 𝑡 = !! !,!!" . ((2.10) 
 
2.1.1 Diffuse Photon Density Waves (DPDWs) 
The work presented in this thesis utilizes Frequency Domain DOS (FD-DOS), 
which is a specific technique of exploiting the photon diffusion equation to quantitatively 
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estimate the tissue optical properties 𝜇! and 𝜇!′.  In FD-DOS, the intensity of the light 
source is modulated sinusoidally at an angular frequency 𝜔.  Thus, a point source at the 
origin can be expressed as: 
 𝑆 𝑟, 𝑡 ≡ (𝑆!" + 𝑆!𝑒!!"#)𝛿(𝑟 = 0). ((2.11) 
This source produces a fluence rate in the medium composed of an AC and a DC 
component that can be expressed as: 
 Φ 𝑟, 𝑡 ≡ Φ!" 𝑟 +Φ 𝑟 𝑒!!"#. ((2.12) 
The AC component of the fluence rate represents the propagation of diffuse photon 
density waves (DPDWs) that result when modulated light travels through a highly 
scattering medium such as tissue [19].  Isolating the AC component of the fluence rate, 
the photon diffusion equation becomes: 
 𝐷∇!  𝛷 𝑟 − 𝑣𝜇!Φ 𝑟 + 𝑣𝑆!𝛿 0 = −𝑖𝜔Φ 𝑟 . ((2.13) 
This equation can be rewritten in Helmholtz equation form as: 
 𝛻! + 𝑘!   Φ 𝑟 = − !!!! 𝛿 0 , ((2.14) 
where 𝑘! = 𝑖𝜔 − 𝑣𝜇! /𝐷.  
For an infinite homogeneous geometry, this equation has a closed form analytical 
solution [18, 19]: 
   Φ 𝑟 = !!!!!" !!"#! , ((2.15) 
where 𝑘 = 𝑘! + 𝑖𝑘! = 𝑖𝜔 − 𝑣𝜇! /𝐷 is the complex wave vector.  Note that this 
solution describes an overdamped spherical wave radiating outward from the source.  
These fluence rate waves are often called diffuse photon density waves (DPDWs) or 
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diffusive waves. The real and imaginary components of the wavevector can be expressed 
as: 
 𝑘! = !!!!! 1+ !!!! ! − 1 !/!; ((2.16) 
T   𝑘! = !!!!! 1+ !!!! ! + 1 !/!. ((2.17) 
Therefore, measurement of 𝑘! and 𝑘! enables determination of tissue 𝜇! and 𝜇!′. 
2.1.2 Semi-Infinite Geometry 
For many real-world biomedical applications, including those presented in this 
thesis, a semi-infinite geometry is more appropriate than an infinite geometry. Here, the 
source and detector optical fibers are placed on the surface of tissue, and boundary 
conditions are imposed on the photon propagation.  A depiction of this geometry is 
shown in Figure 2.  
 
Figure 2: Illustration of a semi-infinite geometry in a homogeneous medium.  The turbid 
homogeneous medium (tissue) with index of refraction 𝑛 is separated by a planar 
boundary at z=0 from a non-scattering medium with index of refraction n0.  
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In the applications of DOS in this thesis, the boundary is often made between 
tissue (𝑛 = 1.4) and silicon rubber (𝑛! = 1.4), which is the material from which we 
make our optical probes that house the fiber optics. Typically, once diffuse light exits the 
tissue into the non-scattering medium, it will never return to the tissue.  We can express 
the total inward radiance at the boundary as the integral of the reflected radiance [17]: 
   𝐸!" = 𝑅!"#$%#&(𝑠)𝐿(𝑠) ∙ 𝑛𝑠𝑖𝑛𝜃𝑑𝜃𝑑𝜙!!/!!!! . ((2.18) 
Here, 𝐸!" is the total incoming diffuse radiance and 𝑅!"#$%#& is the Fresnel reflection 
coefficient, which can be expressed as 
 𝑅!"#$%#&(𝜃)
= 12 𝑛𝑐𝑜𝑠𝜃! − 𝑛!𝑐𝑜𝑠𝜃𝑛𝑐𝑜𝑠𝜃! + 𝑛!𝑐𝑜𝑠𝜃 !/! + 12 𝑛𝑐𝑜𝑠𝜃 − 𝑛!𝑐𝑜𝑠𝜃!𝑛𝑐𝑜𝑠𝜃 + 𝑛!𝑐𝑜𝑠𝜃! !/! ; 0 ≤ 𝜃 ≤ 𝜃!                                                                                                              1                                                                                                 ;𝜃! ≤ 𝜃 ≤ 𝜋/2   
(
(2.19) 
where 𝜃 is the angle of incidence; 𝜃! is the refracted angle; and 𝜃!  is the critical angle. 
Evaluating this equation for the inward radiance using the approximation for nearly 
isotropic radiance yields the partial-flux boundary condition [17]:    
   ϕ = !!!!!!!! (−2𝑗!), ((2.20) 
where 𝑗! is the magnitude of the photon flux in the 𝑧-direction and: 
 𝑅! ≡ 2𝑠𝑖𝑛𝜃!!! 𝑐𝑜𝑠𝜃𝑅!"#$%#&(𝜃)𝑑𝜃; ((2.21) 
 𝑅! ≡ 3𝑠𝑖𝑛𝜃!!! 𝑐𝑜𝑠!𝜃𝑅!"#$%#&(𝜃)𝑑𝜃. ((2.22) 
At the tissue surface, i.e., 𝑧 = 0, the partial-flux boundary condition translates to: 
 ϕ = 2𝐷 !!!!""!!!!"" !!!" , ((2.23) 
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at z=0, where  𝑅!"" is defined as 
 
 
𝑅!"" = !!!!!!!!!!!!. ((2.24) 
However, the partial-flux boundary condition is difficult to use in practice, so we 
approximate with the extrapolated-zero boundary condition where the fluence rate falls to 
zero at a point 𝑧! on the rubber probe side of the boundary (i.e., Φ 𝑧 = −𝑧! = 0), where 𝑧! = − !!!!!  [17].  The method of images can then be used to find the solution to the 
diffusion equation given this boundary condition. 
 
Figure 3: A diagram for the extrapolated boundary condition for the semi-infinite 
geometry.  An extrapolated boundary exists at 𝑧 = −𝑧! where the fluence rate falls to 0.  
The method of images is used to solve for a solution for 𝛷 𝑟 . 
 
 
As shown in Figure 3, given a source placed at 𝑧 = 𝑙!", an added source with the 
same magnitude but opposite sign placed at 𝑧 = −(2𝑧! + 𝑙!") will satisfy the boundary 
condition.  Thus, the solution to the diffusion equation is: 
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  Φ 𝑟 = !!!!!" !!"!!!! − !!"!!!! , ((2.25) 
where 𝑟! = 𝑟! + (𝑧 − 𝑙!")! , 𝑟! = 𝑟! + (𝑧 + 𝑙!" + 2𝑧!)! and 𝑟 = 𝑟  is the source-
detector separation. 
For a source-detector separation 𝑟 = 𝑟 ≫ 𝑙!", the above solution for the 
diffusion equation can be simplified as: 
 
 
  Φ 𝑟 = !!!!!" !!!"!! 2𝑘(𝑙!"𝑧! + 𝑧!!) = 𝐴 𝑟 𝑒!"(!), ((2.26) 
where 𝐴 𝑟  is the amplitude and 𝜃(𝑟) is the phase of the detected light [20, 21].  From 
this equation, the following two relationships can be derived: 
 ln 𝐴 𝑟 𝑟! = −𝑘!𝑟 + 𝐴!; ((2.27) 
 𝜃 𝑟 = 𝑘!𝑟 + 𝜃!. ((2.28) 
where 𝑘! and 𝑘! depend on the absorption and scattering properties of the medium.   
 
Figure 4: Linear relationships used to calculate 𝒌𝒊 and 𝒌𝒓.  The top figure shows the 
linear relationship of 𝐥𝐧 𝑨 𝒓 𝒓𝟐  versus 𝒓, the slope of which is −𝒌𝒊.  The bottom figure 
shows the linear relationship of 𝜽 𝒓  versus 𝒓, the slope of which is 𝒌𝒓. 
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The slope of the linear relationship of ln 𝐴 𝑟 𝑟!  versus 𝑟 is −𝑘!. Similarly, the slope of 
the linear relationship of 𝜃 𝑟  versus 𝑟 is 𝑘!. Thus, by measuring the amplitude 
attenuation and phase shift for multiple values of 𝑟 , the tissue optical properties can be 
calculated from the following equations: 
 µμ! = !!! !!!! − !!!! ; ((2.29) 
 µμ!! = !!!! 𝑘!𝑘!. ((2.30) 
The frequency domain formulation for diffuse optical spectroscopy (FD-DOS) 
provides a very powerful approach to estimate tissue optical properties.  However, 
practical considerations, such as differences in tissue-fiber light coupling efficiencies and 
the need for multiple detector positions, lead to some limitations of the technique.  I 
address these limitations in the following sections. 
2.2 Phantom Calibration 
One primary requirement for the effective use of the FD-DOS formulation is the 
need to make the frequency domain measurements at multiple source-detector 
separations. In practice, measurements at multiple source-detector separations (i.e., 
multiple values of 𝑟 = 𝑟 ) are accomplished by using multiple source fibers placed at 
different distances with respect to a single detection fiber on the surface of the skin.  
Unfortunately, the efficiencies of light coupling of multiple fibers to the tissue cannot be 
assumed to be uniform. Therefore, the measurements must be calibrated to account for 
variations in the transmission of these fibers and variations in laser intensity.  To do this, 
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we define a coupling coefficient for each source,  c!.  Then, the measured fluence rate is 
related to the theoretical fluence rate for the  𝑖!! source by the following equation: 
   Φ!!"#$%&"' = 𝑐!Φ!!!!"#!$%&'(. ((2.31) 
This equation can be expanded to separate the amplitude and phase contributions, 
resulting in the following two equations: 
 𝐴!!"#$%&"' = 𝑐!!A!!!!"#!$%&'(; ((2.32) 
 𝜃!!"#$%&"' = 𝑐!!+θ!!!!"#!$%&'(. ((2.33) 
To determine these coupling coefficients, we conduct measurements on a phantom of 
known optical properties, i.e., a known A!!!!"#!$%&'( and θ!!!!"#!$%&'(. 
2.3 Differential Pathlength Method 
One practical consideration for the FD-DOS formulation is the need to make 
measurements at more than one source detector separation; multiple separations enable 
one to quantitatively estimate tissue optical properties.  When multiple source-detector 
separations are not possible, however, valuable information can still be extracted about 
changes in µμ!(𝜆) over time and thus changes in physiological parameters as a function of 
time (see Section 2.5).  Although the Beer-Lambert Law, in its traditional form, cannot be 
used due to the high-scattering of tissue, a modified version of this law can be derived 
which is useful for estimating changes in the tissue absorption coefficient. This modified 
Beer-Lambert law is written as [22]: 
   ln ! !,!! !,! = Δµμ!(𝜆, 𝑡)𝐿!""(𝜆), ((2.34) 
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or 
 
 
  Δµμ! 𝜆, 𝑡 = !" ! !,!! !,!!!""(!) . ((2.35) 
Here, Δµμ! 𝜆, 𝑡  is the change from baseline (t=0) in the absorption coefficient at 
wavelength 𝜆;  𝐼 𝜆, 𝑡  is the intensity of detected light; and 𝐿!""(𝜆) is the mean optical 
pathlength of detected photons.  𝐿!""(𝜆) depends on the source-detector separation, the 
sample geometry, and the wavelength of light.  For the work presented in this thesis, I use 
a population average value for 𝐿!""(𝜆) for neonates reported by Duncan et al. [23]. 
2.4 Frequency Domain Instrumentation 
The DOS instrument used in this work was a custom designed, commercially 
available device assembled by ISS.  This device contains 16 source laser diodes 
consisting of 4 different wavelengths of light (690nm, 730nm, 780nm, 830nm).  A radio-
frequency (RF) oscillator modulates the amplitude of the light source sinusoidally at 110 
MHz.  The light is delivered to and detected at the tissue surface by optical fibers. The 
device contains two photomultiplier tubes, which are employed for heterodyne detection. 
As opposed to homodyne detection in which the amplitude and phase shifts are 
detected at the same RF carrier frequency that modulates the light source, heterodyne 
detection converts the detected RF signal to a lower frequency before determination of 
the phase shift. In this system, the source signal is modulated at 100 MHz while the 
detection is modulated at 110 MHz + 5kHz. Mixing these two signals yields a slower 
beat frequency of 5kHz, which allow measurement of the phase shift with a higher 
accuracy.  
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2.5 Calculation of Physiological Parameters 
As stated previously, µμ! is related to the concentration of the NIR light absorbing 
chromophores.  The absorption coefficient is essentially a linear combination of the 
extinction coefficient of the chromophores weighted by their concentration in the 
sampling volume and can be described by the following equation: 
 
 
µμ!(𝜆) = 𝜀!(𝜆)𝐶!! . ((2.36) 
Here 𝜀!(𝜆) is the wavelength-dependent extinction coefficient of the 𝑖!! chromophore at 
wavelength 𝜆 and 𝐶! is the concentration of the chromophore.  Assuming that the 
dominant chromophores in brain tissue are oxy-hemoglobin (HbO2), deoxy-hemoglobin 
(Hb), and water (H2O), the measured µμ!(𝜆) of brain tissue can be expressed as: 
] µμ!(𝜆) =    𝜀!"!!(𝜆)𝐶!"!!+𝜀!"(𝜆)𝐶!"+𝜀!!!(𝜆)𝐶!!! ((2.37) 
These extinction coefficients have been measured and reported previously [24]. All of the 
results reported in this thesis were measured using only two wavelengths, 690 nm and 
830 nm; to solve the system of equations for 𝐶!"!! and 𝐶!", I assumed the water 
concentration of brain tissue to be 75% [25]1.  Once 𝐶!"!! and 𝐶!" have been calculated, 
total hemoglobin concentration (THC) and tissue oxygen saturation (StO2) can be 
calculated using the following equations: 
                                                
1 Due to the relatively low absorbance of water in the NIR, an error in the assumed 75% 
water concentration has a minimal effect on the calculated concentrations of Hb and 
HbO2 and thus on StO2. A difference in water concentration of 5% would yield a 
difference in StO2 of approximately 1%.  
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 𝑇𝐻𝐶 = 𝐶!"!! + 𝐶!"; ((2.38) 
 𝑆𝑡𝑂! = !!"!!!"# ×100%. ((2.39) 
Cerebral blood volume (CBV, units of mL/100 g brain tissue) can be calculated from 𝑇𝐻𝐶 from the following formula: 
] 𝐶𝐵𝑉 = !"#×!"!"!"# ×!×!!"×!"! = !.!"×!"#!"# , ((2.40) 
where 𝑀𝑊!"=6.45x104 [g/moles] is the molecular weight of hemoglobin, 𝐻𝑔𝑏  is the 
concentration of arterial hemoglobin, 𝑅=0.69 is the cerebral small-to-large vessel 
hematocrit ratio, and 𝐷!" is the density of brain tissue.  For the results presented in this 
thesis on neonates, the value used for 𝐷!" was 1.05 g/mL [26].   
 Additionally, oxygen extraction fraction (OEF) can be calculated from StO2 and 
arterial oxygenation (SaO2) measured from an arterial blood sample using the following 
formula: 
] 𝑂𝐸𝐹 = !"!!!!"!!!"!! = !! !"!!!!"!!!"!! , ((2.41) 
where 𝛾 is the percentage of blood in the venous compartment and is assumed to be 75% 
[27]. 
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3 Quantification and Validation of Venous Oxygenation 
In the previous chapter, I described DOS and FD-DOS, and I described how this 
technique is used to measure tissue oxygen saturation (StO2).  In this chapter, I describe 
an experiment that I have done to extract only the venous component of the signal. Thus, 
I am able to use DOS to measure venous oxygen saturation (SvO2). The work presented 
in this chapter has been published in [13].  
3.1 Introduction 
Quantitative measures of oxygen extraction are important for assessment of brain 
tissue health in many critically-ill patient populations at risk for altered cerebral 
hemodynamics.  Knowledge of cerebral oxygen extraction helps the clinician balance 
oxygen delivery with cerebral demand thus preventing cell death secondary to metabolic 
failure. 
As explained in Section 2.5, in order to calculate oxygen extraction fraction from 
StO2, one needs to assume that a certain percentage of the probed blood volume, typically 
75%, is from the venous system. This is because optically-measured StO2 represents the 
oxygenation of the microvasculature in the volume underneath the probe, and this tissue 
volume is composed of capillaries, arterioles, and venules.    
While the assumption of 75% provides a rough rule of thumb, it is not always 
valid. Thus, a method for isolating the venous component of the optical signal to quantify 
SvO2 would be very useful. Typically, such schemes require a functional perturbation of 
cerebral blood volume to isolate the venous component of the optical signal, such as 
tilting of the head or venous occlusion [28-30]. However, these perturbation-based 
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measurements do not offer the possibility of continuous monitoring of SvO2.  
Furthermore, the potential to use such perturbations in clinical settings is limited. For 
example, postural manipulation in preterm infants has been shown to cause changes in 
intracranial pressure, increasing the risk of intracranial hemorrhage [31]. 
As an alternative to functional perturbation methods for quantification of SvO2, 
isolation of the venous component of the DOS signal using the oscillations of venous 
blood volume caused by respiratory excursions has been suggested [32-35].  Briefly, the 
method, which we employ herein, relies on the fact that blood volume in the veins 
oscillates at the respiration rate. This sensitivity to the venous portion of the vasculature 
arises because of the relatively large compliance of veins; pressure oscillations induced 
by the diaphragm motion during breathing thus affect the venous components of the 
vasculature much more than the rest of the vasculature [35, 36]. This method has been 
employed in neonates [35] and adults [37],[34],[32], and it has been validated against the 
gold standard venous blood draw in the hind leg of piglets [37]. While encouraging, the 
total number of studies is quite limited, and rigorous validation of this method in humans 
has not been performed.   
In this chapter, I validate this respiratory-frequency-locked DOS method in 
humans for the first time against gold standard invasive measurements of central venous 
saturation.  The investigation was carried out in a human pediatric population with 
pulmonary hypertension undergoing cardiac catheterization. This population is attractive 
for validation, because all subjects are mechanically ventilated at a constant respiration 
rate and because superior vena cava (SVC) saturations are measured as part of the clinical 
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protocol.  In addition, I applied this method to five healthy volunteers to demonstrate that 
it can be generalized to populations whose respiration rate is volitionally, not 
mechanically, controlled. 
 
3.2 Materials and Methods 
3.2.1 Population 
The pulmonary hypertension team at the Children’s Hospital of Philadelphia 
identified and screened for study inclusion all patients undergoing cardiac catheterization 
to diagnose or treat pulmonary hypertension and who were approached for participation.  
All subjects had pulmonary hypertension and were receiving an intravascular 
catheterization procedure for clinical purposes.  Blood samples from the SVC were 
obtained as part of the clinical procedure to quantify venous oxygenation.  
In addition to this validation study, five healthy adult volunteers were recruited to 
test the method feasibility for use in other populations. 
This study was approved by the Children’s Hospital of Philadelphia Institutional 
Review Board.     
3.2.2 Study Protocol 
All subjects in the validation study were placed under general anesthesia (via 
sevo- and isoflurane and pancuronium) and mechanically ventilated on room air.  After 
sedation, a flexible black rubber optical probe was placed on the right or left side of the 
subject’s forehead and secured with an elastic bandage.  As a part of routine clinical care, 
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a central venous catheter was placed, using access from the right internal jugular vein 
(n=3) or a femoral vein (n=7). Access to the superior vena cava (SVC), between the right 
subclavian and left innominate veins, was thus obtained and confirmed with 
fluoroscopy.  After hemodynamic stability was confirmed, a blood sample from the SVC 
was obtained and cerebral venous oxygen saturation (SvO2SVC) was quantified using a 
whole blood oximeter (Avoximeter 1000E).  Immediately after obtaining the SVC blood 
sample, DOS data were acquired continuously at 6 Hz for 2 minutes in order to optically 
derive SvO2.  Vital signs, including blood pressure and heart rate, were monitored 
continuously.  
To demonstrate the feasibility of the frequency-filtered, non-invasive DOS 
method in other populations (e.g., non-ventilated healthy humans), we acquired optical 
data from five healthy volunteers.  The same optical probe was secured to the volunteer’s 
forehead with an elastic bandage.  DOS data were acquired for 10 minutes at 
approximately 6 Hz.  During data acquisition, the subject was instructed to inhale to the 
beat of a metronome set at the subject’s resting state respiration (approximately 0.18 Hz) 
in order to maintain a steady respiration rate. 
 
3.2.3 Data Analysis 
The optically derived DOS data was first processed to estimate changes in 
concentrations of oxy- and deoxy-hemoglobin, using the procedure described in Section 
2.3.  Using the time series of Δ[HbO2] and Δ[Hb] and following the method outlined in 
[37], I derive a measure of venous oxygen saturation, which I denote herein as SvO2DOS, 
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that represents the microvasculature underneath the optical probe that is secured to the 
subject’s forehead. Briefly, this method quantifies the changes in [HbO2] and [Hb] which 
occur at the respiration frequency and makes the assumption that these changes are 
happening mostly in the veins.   
Specifically, I apply a narrow bandpass frequency filter (filter.m, Mathworks) to 
the concentration time series, in order to select contributions only from frequencies 
within 1% of the subject’s known respiration rate.  The resultant filtered times series of 
[HbO2] and [Hb] variation, i.e., with frequencies within 1% of the respiration rate, is due 
to mostly venous blood, since the venous blood volume will be oscillating predominantly 
at this frequency.  This resultant filtered time series is exhibited in Figure 5e and f.  I 
assume that the saturation of the blood that is displaced from the veins during respiration 
is representative of the saturation of all venous blood.   I calculate the saturation of the 
displaced blood by first quantifying the amplitudes for each period of these filtered time 
series, denoted herein as 𝐴! Hb !"#$ and 𝐴! HbO2 !"#$. Then SvO2DOS is calculated for each 
period as 
 
SvO!!"#$ = !! HbO2 !"!"!! Hb !"#$!!! HbO2 !"#$ ×100%. ((3.1) 
A value of SvO2DOS for each subject is obtained by averaging over all periods. 
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Figure 5: Sample unfiltered time series, Fourier transform, and filtered time 
series of Δ[Hb] and Δ[HbO2]. Figures (a) and (b) depict unfiltered time series of 
Δ[Hb] (and Δ[HbO2], respectively. Figures (c) and (d) show the Fourier transform 
of the Δ[Hb] time series and the Δ[HbO2] time series, respectively. The dashed 
lines mark the respiration rate, the second harmonic of the respiration rate, and the 
heart rate.  The bottom two plots show sample time series of Δ[Hb] (e) and 
Δ[HbO2] (f) after bandpass filtering at the respiration rate/frequency. 
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The data quality of this measurement is related to the signal strength at the 
respiration rate/frequency. To evaluate this signal strength, I compare the peak of the 
Fourier component of the signal at the respiration rate/frequency to the standard deviation 
of the Fourier components of the signal at nearby frequencies.  Specifically, I define a 
signal-to-noise ratio for both Δ[Hb] and Δ[HbO2] to be 𝑆𝑁𝑅!" = !!"(!") !"#$!!"#$!!"#$!!"#$  and 𝑆𝑁𝑅!"#! = !!"(!"!!) !"#$!!"#$!!"#$!!"#$ , respectively.  Here 𝐹𝐹𝑇(𝐻𝑏) !"#$!!"#$ is the peak of 
the Fourier signal of Δ[Hb] at the respiration frequency (Figure 5), and 𝜎!"#$!!"#$ is the 
standard deviation of the Fourier signals at frequencies between the respiration 
rate/frequency and 32.5 mHz less than the respiration rate/frequency. In practice, I only 
utilize the standard deviation at lower frequencies, because the variance in the Fourier 
signal of the lower frequencies is large compared to that at the higher frequencies.  All 
data with 𝑆𝑁𝑅!"#! < 2.5 and/or 𝑆𝑁𝑅!" < 2.5 is excluded from the subsequent analysis. 
This process is summarized in Figure 6.   
3.2.4 Statistical Analysis 
All statistical analyses were performed using R 2.11 software [38].  Statistical 
significance was declared for 𝑝-values < 0.05. To quantify the relationship between 
venous saturation measured non-invasively with DOS (SvO2DOS) and venous saturation 
measured from blood samples drawn from the SVC (SVO2SVC), I fit a simple linear 
regression model.  I report the Pearson’s correlation coefficient, 𝑅, which varies from 0 
to 1.0 to estimate the extent to which a linear model explains variability in the data. Note 
that 𝑅 gives only a measure of linear correlation. To quantify the agreement between 
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SvO2DOS and SVO2SVC, we report Lin’s concordance correlation coefficient, CCC, which 
combines a measure of precision and accuracy [39].  A Bland-Altman plot was 
constructed to visualize the extent of agreement between the two methods [40]. 
 
Figure 6: Flowchart of data processing for calculation of SvO2DOS. 
3.3 Results 
3.3.1 Validation Study 
Twenty-two patients were consented for this study.  Of this population, 10 
patients (with ages from 2 months to 14 years) had both SVC blood samples obtained 
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during the catheterization and usable optical data (i.e., based on the criteria stated in 
Section 2.3).  Patient characteristics are summarized in Table 1.   
Table 1: List of patient demographics for validation study of DOS measured SvO2.  
Continuous variable are listed as median (interquartile range, IQR). 
 Median (IQR) 
Age (yrs) 5.3 (1.3, 9.7) 
Weight (kg) 15.3 (8.7, 24.1) 
Height (cm) 99.9 (69.9, 124.8) 
Sex (Male:Female) 5:5 
 
Table 2: List of measured parameters during cardiac catheterization for validation study 
of DOS measured SvO2.  Continuous variables are listed as median (interquartile range, 
IQR). 
 Median (IQR) 
Respiration Rate (breaths per min) 20 (17, 20) 
Heart Rate (beats per min) 103 (87, 134) 
SvO2SVC (%) 64 (62, 67) 
SvO2DOS (%) 59.6 (56.4, 65.9) 𝑆𝑁𝑅!" 50.0 (16.5, 111.0) 𝑆𝑁𝑅!"#! 25.5 (18.4, 51.8) 
 
Table 2 shows median (interquartile range, IQR) SvO2 measured with both DOS 
and co-oximetry. As shown in Figure 7, we see a strong and significant linear 
relationship  (𝑅! = 0.80, 𝑝 < 0.001) between optically measured SvO2DOS and the 
venous saturation measured invasively from the SVC (SvO2SVC) with a slope (95% 
confidence interval) of 1.16  (0.68, 1.64).  The Bland-Altman plot (Figure 8) for these 
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two measurements suggests good agreement, with a mean difference of 2.61  (−4.56, 9.77).  The concordance coefficient of 0.80 is high. 
 
Figure 7: Cerebral venous saturation measured with near-infrared spectroscopy 
compared to venous saturation measured from a blood sample invasively taken from the 
SVC. The solid line represents the best-fit line to the data (R2=0.80, p<0.001); the dashed 
line indicates the line of perfect concordance; and the gray ribbon denotes the 95% 
confidence interval for the mean SvO2NIRS.  
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Figure 8: Bland-Altman plot of the difference in SvO2DOS and SvO2NIRS versus the mean 
of these two parameters.  The solid horizontal line indicates the mean difference between 
these two parameters; the dotted lines indicate the 95% limits of agreement.  
3.3.2 Healthy Volunteers 
To demonstrate feasibility in other populations, SvO2DOS was measured in five 
healthy volunteers. The average (standard deviation) SvO2DOS calculated over a 10 
minute period in each healthy subject was 79.4 (6.8)%.  This value is in good agreement 
with the expected average central venous saturation for a healthy adult of 76.8±1.0% 
[41].  Importantly, even though these subjects were awake and were not using a 
respirator, the data quality was sufficient for accurate determination of SvO2DOS in each 
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subject, with an average (standard deviation) 𝑆𝑁𝑅!"!!   of 57.6 (33.8) and  𝑆𝑁𝑅!" of 31.9 
(27.5). 
 
3.4 Discussion 
Significant  (𝑅! = 0.80,𝑝 < 0.001) correlation and agreement   (slope = 1.16±0.48) was observed between cerebral venous saturations determined by respiration-
frequency filtered DOS and by the gold standard measurement of central venous 
saturation, i.e., oximetry of blood samples taken from the SVC. SvO2DOS is a measure of 
the venous saturation in the microvasculature underneath the optical probe that is secured 
to the subject forehead.  SvO2SVC is a measure of central venous saturation, which 
includes venous saturation of the brain and upper extremities.  Roughly speaking, we 
would expect these values to be similar in anesthetized patients wherein the vast majority 
of oxygen consumption occurs in the brain.  Thus, even though the two methods derive 
venous saturation from two different vasculatures, the agreement between them is 
encouraging.  
I measured SvO2DOS in free-breathing volunteers to demonstrate the feasibility of 
this technique in subjects who are not mechanically ventilated. The measured SvO2DOS in 
the healthy volunteers is in good agreement with the average central venous saturation for 
a healthy adult of 76.8±1.0% [41] illustrating feasibility of this method in other (less-
controlled) populations.   
One of the main limitations of the optical method derives from use of a bandpass 
filter for isolating the respiration frequency. Optical data were acquired on 20 subjects; 
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however, SvO2DOS was only calculated for 10 of these subjects due to poor 𝑆𝑁𝑅!"!! or 
poor 𝑆𝑁𝑅!". I found that lowering this SNR cut-off to below 2 in this patient group 
introduces significantly more scatter into the total population data, thus it is imperative to 
maintain a high SNR for this measurement.  To illustrate the effect of this SNR cut-off on 
the validation results reported herein, Figure 9 shows the R2 and p-value and the number 
of subjects for the correlation between SvO2DOS and SvO2SVC for different values of this 
SNR cut-off. 
 
Figure 9: The effect of the SNR cutoff for validation of SvO2DOS.  For different values of 
the SNR cutoff, the plots show the effect on the R2 value of the correlation between 
SvO2DOS and SvO2SVC (top), on the p-value of this correlation (middle), and on the 
number of subjects that pass this cut-off (bottom). 
Many factors can contribute to poor SNR, all of which lead to a less pronounced 
signal peak at the respiration rate in the frequency domain.  These factors include motion 
artifacts, low amplitude of detected light, and irregular respiration.  To minimize motion 
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artifacts, I found that it is imperative to secure the optical probe with an elastic bandage, 
e.g., instead of manually holding the probe during measurement.  This adjustment in the 
measurement protocol yielded improved data quality in later recruited subjects.  I also 
observed that SNR can be improved by acquiring data for longer than 2 minutes, but due 
to the restraints of the clinical setting, improvement of SNR was not possible in this 
study.  In future studies, this SNR criteria can provide a useful new filter for data quality 
for this measurement. 
Despite the caveats noted above, the method proved to work quite well in this 
patient population.  Our worst deviation from SvO2SVC was less than 10%, which is 
encouraging given the approximate nature of the models used in the analysis.  Of note, 
SvO2DOS is a measure of the local venous saturation of the vasculature probed by the NIR 
light.  In many cases of injury or impairment wherein heterogeneity of cerebral 
saturations may exist, e.g., stroke, hemorrhage, etc., the optical method need not yield a 
quantity that is representative of the global cerebral SvO2 and thus should not be expected 
to agree with SvO2SVC.  These deviations, however, could find use for monitoring local 
injury and therapy responses.   
3.5 Conclusion/Future 
In this chapter, I have validated respiratory-frequency filtered diffuse optical 
spectroscopy (DOS) as a measure of cerebral venous oxygen saturation against a gold 
standard measurement in humans.  Specifically, I employed DOS to measure SvO2DOS 
immediately after clinicians measured SvO2SVC and found good agreement between these 
two methods.  I also demonstrated the feasibility for generalizing this method to other 
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populations by measuring SvO2DOS in healthy volunteers.  Validation of this technique 
against the clinical gold standard in humans is the first step towards its wide use in 
clinical setting.  Further work is needed to realize the potential of this non-invasive 
monitor of cerebral SvO2 for management of critically ill patients with high risk of 
ischemic brain injury. Specifically, maximizing the SNR is crucial for widespread use of 
this technique. Along these lines, future work will focus on the use of this method in 
patients who are not mechanically ventilated and thus may not have a steady respiration 
rate. 
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4 Diffuse Correlation Spectroscopy 
In this section, I will describe a second optical technique that is used to probe the 
dynamic properties of tissue, namely blood flow.  I begin this chapter by discussing 
dynamic light scattering, which utilizes speckle fluctuations to derive information on the 
motion of small particles.  Diffusion correlation spectroscopy (DCS) is similar to 
dynamic light scattering, in that it derives information on the motion of red blood cells 
using the speckle fluctuations of light that has traveled through biological tissue [42, 43].  
I will discuss both techniques, and then I will describe the DCS instrument that I 
assembled and troubleshot which was used for the work presented in this thesis. I will 
then describe work that I have done in validating DCS in infants with congenital heart 
disease.  Finally, I will demonstrate the clinical usefulness of DCS by describing a 
clinical study in which I utilized DCS to quantify changes in cerebral blood flow due to a 
clinically administered drug called adenosine.   
4.1 Dynamic Light Scattering 
Dynamic light scattering (DLS) is a method of measuring the motion of particles 
in a suspension using scattered light.  In the single-scattering limit, the suspension is 
assumed to be dilute enough such that light traveling through the sample is either 
scattered once or not at all. 
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Figure 10: Illustration depicting dynamic light scattering in the single scattering limit. 
 
As seen in Figure 10, in this single-scattering experiment, the incident light electric field 
(𝑘!") is scattered by an angle which results in a momentum transfer, 𝑞 = 𝑘!"# − 𝑘!".  The 
motion of particles and the scattering of the light cause constructive and destructive 
interference patterns for the light electric field at the detector, 𝐸 𝑡 , which changes over 
time.  For independent particles, these detected fluctuations can be described by the 
normalized electric field temporal auto-correlation function [44-46]:  
T g1 𝜏 = !∗ ! ∙! !!!! ! ! = 𝑒!!!"#𝑒!!! ∆!! ! /!. ((4.1) 
Here, 𝑓 is the frequency of incident light, and ∆𝑟! 𝜏  is the mean-square displacement 
of particles where      denotes an ensemble average, which is assumed to be the same as 
the time average for the data presented in this thesis (and for most situations). For 
Brownian motion,   ∆𝑟! 𝜏 = 6𝐷!𝜏, where 𝐷!is an effective Brownian diffusion 
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coefficient of the particle.  For random flow, ∆𝑟! 𝜏 = 𝑉! 𝜏!, where 𝑉 is the second 
moment of the particle speed distribution.   
 In experiments, the light intensity auto-correlation function, g2(𝜏), is often 
detected instead of the electric field auto-correlation function.  The normalized intensity 
temporal auto-correlation function is defined as: 
T g2(𝜏) = ! ! !(!!!)!(!)! . ((4.2) 
g2(𝜏) is related to g1(𝜏) by the Siegert relation: 
T g2 𝜏 = 1+ 𝛽 𝑔!(𝜏) !. ((4.3) 
Here, 𝛽 is inversely proportional to the number of detected light modes and is thus a 
constant that depends on the detection optics, coherence length and stability of the laser, 
and ambient light. Note, the Siegert relation is valid for Gaussian sources. 
4.2 Correlation Diffusion Equation 
In the above section, I described the single-scattering limit of DLS.  However, 
biological tissue is a highly scattering medium.  Ackerson et al [47] suggested that in this 
case, the unnormalized electric field auto-correlation function,  
G1(𝜏) = 𝐸∗(𝑟, 𝑡) ∙ 𝐸(𝑟, 𝑡 + 𝜏) , is analogous to the radiance  and thus should obey a 
correlation transfer equation: ∇ ∙ G1 𝑟, 𝑠, 𝜏 𝑠 + 𝜇!G1 𝑟, 𝑠, 𝜏= 𝑄 𝑟, 𝑠 + 𝜇! G1 𝑟, 𝑠′, 𝜏 g1(𝑠, 𝑠′, 𝜏)𝑓(𝑠, 𝑠!)𝑑s′∙  (4.4) 
As with the RTE, this correlation transport equation can be reduced to a correlation 
diffusion equation, and was done so by Boas et al. [42, 43]: 
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T ∇ ∙ 𝐷 𝑟 ∇ − 𝑣𝜇! 𝑟 − !! 𝑣𝜇!′𝑘!! Δ𝑟!(𝜏) G1 𝑟, 𝜏 = −𝑣𝑆(𝑟). ((4.5) 
Here, 𝜇!, 𝜇!′, 𝐷, and 𝑣 are the same as in the photon diffusion equation (see Section 2.1); 𝛼 is the fraction of scattering events that occur from moving particles; k! is the 
wavenumber of light diffusion through the medium, and, again, Δ𝑟!(𝜏)  is the mean-
square displacement of the scattering particles.  The main moving scatterers in tissue 
detected by DCS are red blood cells.   
 Several assumptions must be made in the derivation of this equation and have 
been described in depth [18]. Briefly, this equation assumes that the medium is highly 
scattering and isotropic, the scatterers are randomly oriented and have isotropic 
dynamics, and the correlation time is much less than the time it takes for the individual 
scatterers to move the wavelength of light. 
 The solutions for the correlation diffusion equation have the same form as the 
solutions for the photon diffusion equation.  For the work presented in this thesis, I again 
assume a semi-infinite homogeneous medium with a tissue-silicon planar interface.  
Thus, the semi-infinite solution of G1 𝑟, 𝜏  using an extrapolated boundary condition 
(G1 𝑧 = −𝑧! , 𝜏 = 0) and obtained with the method of images is (see Section 2.1) [18]: 
T G1 𝑟, 𝜏 = !!!!!!!! !!! ! !!!! − !!! ! !!!! , ((4.6) 
where  
T 𝜅 𝜏 = !! 𝜇! + !! 𝜇!′𝑘!! Δ𝑟!(𝜏) . ((4.7) 
As with the solution for the photon diffusion equation, 𝑟! = 𝑟! + (𝑧 − 𝑙!")!, 𝑟! = 𝑟! + (𝑧 + 𝑙!" + 2𝑧!)!, and 𝑙!" = 1/𝜇!′. The parameters 𝛼 and Δ𝑟!(𝜏)  are 
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related to the dynamics of the scatterers, i.e., blood flow. Due to the complex nature of 
microvasculature, we may expect the motion of the red blood cells to be nearly isotropic 
and that the mean-square displacement of particles can be described as random flow (i.e., ∆𝑟! 𝜏 = 𝑉! 𝜏!). However, in practice, we find that the observed auto-correlation 
function more closely resembles the Brownian diffusion model (i.e., ∆𝑟! 𝜏 = 6𝐷!𝜏).  
Thus, the equation for 𝜅 𝜏  becomes:  
T 𝜅 𝜏 = !! 𝜇! + !! 𝜇!′𝜅!! 6𝐷!𝜏, ((4.8) 
where 𝛼𝐷! depends on tissue dynamics.  In the work presented in this thesis, the 𝜇! and 𝜇!′ values measured with DOS are used for the fitting of the detected temporal intensity 
auto-correlation curve. We define a blood flow index, BFI: 
T 𝐵𝐹𝐼 ≡ 𝛼𝐷!. ((4.9) 
A typical value for BFI for human brain tissue is of the order of 1x10-8 cm2/s.   
To illustrate how the measured intensity auto-correlation curves, and thus the 
fitted value for BFI, relate to cerebral blood flow, Figure 11 shows sample DCS data 
taken on the frontal cortex of an infant breathing room air (red curve), and then later 
breathing a mixture of room air and added CO2.  CO2 acts as a cerebrovascular 
vasodilator and causes a significant increase in cerebral blood flow [48, 49].  As can be 
seen in Figure 11, the decay rate of g2 decreases under these conditions, called 
hypercapnia.  The fitted values of BFI for these two curves reflect the difference between 
the decay rates. BFI under the room air condition is 3.95x10-8 cm2/s, while BFI under 
hypercapnia is 10.5x10-8 cm2/s.  
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Figure 11: Sample DCS data from the frontal cortex of an infant undergoing a 
hypercapnia intervention.  The red curve is the intensity auto-correlation curve from a 
frame of data taken when the patient was breathing room air.  The blue curve is under 
hypercapnia.   
 
In the following sections, I will describe the instrumentation used to measure BFI 
as well as validation studies comparing this value to other modalities for measuring 
cerebral blood flow. 
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4.3 Instrumentation 
Figure 12 shows the DCS instrument that I assembled, troubleshot, and used for 
the work presented herein.
 
Figure 12: Picture of DCS module used in the work presented in this thesis. 
This particular module consists of two long coherence length lasers with optical isolators 
operating at 785 nm.   This wavelength was chosen due to its proximity to the isosbestic 
point at 810 nm where the absorption spectra of oxy- and deoxy-hemoglobin intersect in 
the near-infrared.  On the detection end, eight single-mode fibers are coupled to 2 4-
channel avalanche photon diodes (APDs).  The detected signal is then fed into an 8-
channel correlator that derives the intensity autocorrelation function based on photon 
arrival times.  Table 3 provides a comprehensive parts list for the components of this 8-
channel DCS module. 
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Table 3: Parts list for an 8-Channel, 2 laser DCS box. 
Item Quantity Manufacturer/Distributor Part Number 
Long-coherence length 
lasers with optical isolator 
2 Crystalaser DL785-100-3O 
4-Channel APD 2 Pacer SPCM-AQ4C 
4-Channel interface card 1 Pacer SPCM-AQ4C-IO 
8-Channel correlator 1 Correlator.com Flex05-8ch 
+5 V Power supply 1 Murata SWS50-5 
+28 V Power supply 1 Lambda HSB-28-1.0 
+2 V Power supply 1 ASTEC LPT81 
Data Acquisition Module 1 National Instrument 780115-01 
Box enclosure 1 Newark 86F936 
Lumex Indicator Light 2 Allied Electronics, Inc. 670-1305 
Electroswitch Toggle 2 Allied Electronics, Inc. 747-0029 
309 Ohm .125W Resistor 2 Allied Electronics, Inc. 70200773 
50 Ohm 3W Resistor 5 Allied Electronics, Inc. 70201568 
 
   
4.4 Validation Studies 
DCS has been validated against multiple clinical modalities and in a variety of 
tissues [48-53].  Table 4 summarizes validation studies that compare relative changes in 
BFI measured with DCS against various “more” established modalities for measuring 
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cerebral blood flow (CBF) in humans. I contributed significantly to the data acquisition 
and interpretation of the validation study published by Buckley et al [48]. 
Table 4: Summary of validation studies of DCS measurements of changes in BFI in 
human brain due to a perturbation. 
Age Modality Perturbation Correlation Coefficient Slope Reference 
Infant ASL-MRI Hypercapnia 0.7 0.85 [49] 
Child VENC-MRI Hypercapnia 0.86 0.85-1.03 [48] 
Adult Xenon-CT Pressors & 
Hyperventilation 
0.73 1.1 [52] 
ASL-MRI, arterial spin labeling magnetic resonance imaging; VENC-MRI, velocity 
encoded magnetic resonance imaging; Xenon-CT, xenon-enhanced computer 
tomography. 
In addition to the validation studies shown in Table 4, I participated substantially in 
studies that aimed to validate absolute BFI in a subpopulation of the cohort reported in 
Section 6 (infants with CHD).  For this work, which has been published [14], I played an 
integral role in data acquisition and data interpretation. Specifically, we compared BFI 
measured with optics to CBF measured in the sagittal sinus with velocity-encoded 
(VENC) MRI, i.e., VENC-MRI.  We observed a significant correlation between BFI 
measured with optical-DCS and CBF measured with VENC-MRI (R2=0.25, p=0.01) 
(Figure 13).  The BFI in this comparison was calculated by fitting the intensity temporal 
auto-correlation curve while using values of 𝜇! and 𝜇!′ measured in each patient by DOS.  
In following section, I discuss the effect of 𝜇!′ on this validation of BFI, and indicate 
areas for future work. 
 44 
 
Figure 13: Correlation of BFI measured with optics and CBF measured with VENC-
MRI. The black line denotes the line of best fit to the data (R2=0.25, p=0.01). This work 
has been published [14]. 
4.5 Effect of optical properties on BFI 
The effect of the values for 𝜇! and 𝜇!′ in calculations of BFI has been described 
in reference [11].  One conclusion from that discussion is that the parameter 𝜇!′ has a 
much greater influence on BFI than 𝜇!.  Therefore, errors in 𝜇!′ have more impact on 
BFI than errors in 𝜇!.  In Section 6 of this thesis, I will report BFI values for a population 
of infants with complex congenital heart disease.  In this section, I briefly describe the 
effect of 𝜇!′ in the validation studies of BFI against VENC-MRI within a subset of this 
patient population [14]. 
In the previous section, I showed a correlation (R2=0.25, p=0.01) between BFI 
measured with DCS and CBF measured with VENC-MRI, i.e., within in a subpopulation 
of the cohort presented in this thesis [14].  The BFI values used in the comparison were 
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calculated from the measured intensity temporal auto-correlation curve using each 
patient’s measured 𝜇!′.  BFI also is calculated this way for the results reported in Section 
6 of this thesis. Perhaps surprisingly, when we calculated BFI assuming a fixed value 𝜇!′ 
for all subjects, then the measurements of BFI and CBF exhibit a higher correlation.  The 
value assumed for 𝜇!′ had a significant effect on the slope of the BFI-CBF correlation, 
but not on the correlation coefficient.   
 
Figure 14: Comparison of BFI calculated using various values of 𝝁𝒔′ to CBF measured 
with VENC-MRI. Each set of data has a line of best fit.  Interestingly, the correlation 
between BFI and CBF seems to improve when assumed value of 𝝁𝒔′ is used across all 
subjects for calculating BFI.  
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This observation is puzzling.  Random and systematic noise in measured 𝜇!′ must 
account for this effect. One possible explanation for the improvement of the correlation 
when assuming a fixed value for 𝜇!′ for the entire population is that DOS is more 
sensitive to the superficial layers (i.e., the skull and scalp) than DCS, i.e., due to the 
multiple source-detector separations used for DOS.Further, we have found that our 
measurements of 𝜇!′ typically had errors larger than 20% in these geometries and with 
these probes. This issue is deserving of further study; we have not resolved it.  
Nevertheless, we continue to use measured 𝜇!′ in this thesis. 
4.6 Cerebral effects of intravenous adenosine 
DCS is a highly useful tool in clinical studies, as it enables non-invasive 
quantification of CBF and can be used at the patient’s bedside and other 
operating/imaging suites throughout the hospital.  In this section, I describe a clinical 
investigation that I conducted using DCS in patients undergoing cardiac imaging in a 
magnetic resonance (MR) suite. This study was performed to understand the effects on 
cerebral blood flow of adenosine, a drug given as part of clinical protocol for cardiac 
stress MRIs. 
4.6.1 Introduction 
Adenosine is a nucleoside that is present in the body and plays an important role 
in the regulation of vascular tone and thus the regulation of blood flow [54].  When given 
intravenously, adenosine has a vasodilatory effect on the coronary arteries.  Because of 
this, adenosine infusions are often given in cardiac stress tests to evaluate myocardial 
perfusion.  Specifically, patients complaining of chest pain, or children whose coronary 
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arteries have been manipulated due to prior cardiac surgery, undergo an adenosine stress 
cardiac MRI (ACMRI) in order to measure myocardial perfusion during resting state and 
during stress induced by the adenosine infusion. 
While the effect of adenosine on the coronary arteries are well known, the 
cerebral effects of adenosine are poorly understood.  There have been a few experimental 
studies on the effects of adenosine on cerebral hemodynamics, but these studies have 
conflicting results [55-58]. Sollevi et al. observed an increase in CBF measured with 
positron emission tomography (PET) in normoventilated, anesthetized human subjects 
upon receiving an infusion of adenosine [58].  Increases in CBF due to adenosine have 
also been observed in rabbits and baboons [55, 56].  However, Hussain et al. observed no 
change in CBF due to adenosine in awake humans [57], and others have reported that 
CBF does not change due to adenosine in cats and dogs [56]. 
Understanding the effects of intravenous adenosine on the cerebral vasculature is 
important for understanding the role of adenosine in regulating cerebral blood flow. In 
this study, I used DCS and DOS to non-invasively quantify changes in cerebral blood 
flow and oxygenation due to adenosine infusions during these cardiac stress tests. 
4.6.2 Methods 
Study Protocol 
This study was approved by the Children’s Hospital of Philadelphia Institutional 
Review Board.  All patients undergoing an adenosine stress cardiac MRI (ACMRI) were 
evaluated for study inclusion.  Patients were either induced under general anesthesia or 
stayed awake for the ACMRI. The subset of patients placed under general anesthesia 
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were induced with Sevoflorane.  After induction of anesthesia (when used) and before the 
cardiac MRI, baseline DOS measurements of µμ! and µμ!′ were acquired on both sides of 
the forehead.  Once the patient is placed inside of the MRI scanner, an optical probe with 
one source-detector separation (see Section 2.3) was placed on the forehead and left on 
for the duration of the ACMRI.2  All ACMRI were performed on the same scanner; 
Siemens Avanto 1.5T (Siemens Medical Systems, Malvern, NJ, USA). The duration of 
the ACMRI is approximately 60 minutes, during which MRI scans of the heart are 
acquired for baseline and post-infusion conditions.  After the baseline scans are acquired, 
a cardiac anesthesiologist administers the intravenous adenosine infusion at a dosage of 
140 micrograms/kg/min over 6 minutes.  
Vital sign data were captured from clinical monitors using the Moberg CNS 1000 
monitor (Moberg, Ambler, PA, USA).  Optical data was acquired continuously 
throughout the duration of the ACMRI at a frame rate of approximately 0.3 Hz.  Changes 
in µμ! were calculated from the baseline values taken before the MRI (see Section 2.3). 
The relative change in CBF (rCBF) due to the adenosine infusion was quantified by 
comparing an average BFI during the pre-infusion period to an average at the end of the 
6-minute infusion period via the following formula:   
T 𝑟𝐶𝐵𝐹 = !"# During!"# Pre ×100%. ((4.10) 
                                                
2 The use of a single source-detector separation was due to the lack of availability of an 
MR compatible probe with multiple source-detector separations.  The probe with multiple 
source-detector separations used for baseline measurements was not MR compatible, and 
the fibers were not long enough to extend from the instrument which is placed in an 
adjoining control room to the patient in the scanner. 
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Here,     denotes an average over 2 minutes either immediately before the adenosine 
infusion or during the last 2 minutes of the infusion (Figure 15).  Similarly, changes in 
the total hemoglobin concentration THC, heart rate (HR), and mean arterial pressure 
(MAP) were calculated from the following formulas: 
T Δ𝑇𝐻𝐶 = 𝑇𝐻𝐶 During − 𝑇𝐻𝐶 Pre, ((4.11) 
≈ Δ𝐻𝑅 = 𝐻𝑅 During − 𝐻𝑅 Pre. (
(4.12) 
≈ Δ𝑀𝐴𝑃 = 𝑀𝐴𝑃 During − 𝑀𝐴𝑃 Pre. (
(4.13) 
 
Figure 15: Schematic of study protocol.  Optics and vitals data are recorded continuously 
throughout the duration of the MRI.  The adenosine infusion lasts 6 minutes.  Variables 
of interest are averaged over a 2-minute pre-infusion period and compared to an average 
during the last 2 minutes of the infusion. 
 
4.6.3 Results 
A total of N=20 patients were studied, and patient demographics are summarized 
in Table 5.  Patients were predominately male, and the subgroup of patients who were 
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anesthetized for the ACMRI were significantly younger than those who were awake 
(p<0.01). 
Table 5: Summary of demographic data for subjects studied undergoing an ACMR. 
Group N Female (n) 
Age 
(years) 
Weight 
(kg) 
Awake 11 0 16.0±2.9 70.3 ±15.2 
     
Anesthetized 9 2 9.1±3.3 36.9±20.6 
     
All 20 2 12.9±3.1 55.3±17.6 
 
We observed a significant (p=0.005) difference in the change of CBF due to 
adenosine between the group of patients who were anesthetized and those who were 
awake for the ACMRI (Figure 16).  Specifically, subjects who were awake for the 
ACMRI, had, on average, an increase in CBF due to adenosine, whereas the subjects who 
were anesthetized for the ACMRI had, on average, a decrease in CBF due to adenosine.  
We did not observe a significant difference between these two groups in the change in 
THC due to adenosine (Figure 17).  Both groups had an increase in HR, but the group of 
subjects who were awake for the ACMRI had a significantly greater increase in HR due 
to adenosine (Figure 18).  Additionally, the group of subjects who were anesthetized had 
a decrease in MAP whereas the group of subjects who were awake had, on average, no 
change in MAP due to adenosine. 
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Figure 16: Changes in CBF due to an adenosine infusion in patients who are awake 
(N=11) or anesthetized (N=9) during the infusion.  Patients who were awake during 
induction had a significant increase in CBF. The red line denotes the median value; the 
blue square extends to the 25th and 75th percentiles; the whiskers extend to the most 
extreme data points that are not outliers; and the outliers are plotted as individual points. 
 
 
Figure 17: Changes in THC due to an adenosine infusion in patients who are awake 
(N=11) or anesthetized (N=9) during the infusion.  There was no observed significant 
difference in change in THC due to adenosine between the two subgroups. The red line 
denotes the median value; the blue square extends to the 25th and 75th percentiles; the 
whiskers extend to the most extreme data points that are not outliers; and the outliers are 
plotted as individual points. 
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Figure 18: Changes in HR due to an adenosine infusion in patients who are awake 
(N=11) or anesthetized (N=9) during the infusion.  Patients who were awake during 
induction had a significantly larger increase in HR due to adenosine. The red line denotes 
the median value; the blue square extends to the 25th and 75th percentiles; the whiskers 
extend to the most extreme data points that are not outliers; and the outliers are plotted as 
individual points. 
 
Figure 19: Changes in MAP due to an adenosine infusion in patients who are awake 
(N=11) or anesthetized (N=9) during the infusion.  Patients who were awake during 
induction had on average no change in MAP, whereas patients who were anesthetized 
had a decrease in MAP due to adenosine. The red line denotes the median value; the blue 
square extends to the 25th and 75th percentiles; the whiskers extend to the most extreme 
data points that are not outliers; and the outliers are plotted as individual points. 
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4.6.4 Discussion 
We observed that the effect of an intravenous adenosine infusion on CBF depends 
on whether or not the patient is anesthetized.  This observation may explain some of the 
discrepancies reported seen in the literature.  Additionally, we do not see an average 
increase in THC due to adenosine in either group. Since THC is related to cerebral blood 
volume (CBV), which should increase when there is vasodilation, the results herein 
suggests that perhaps adenosine does not have a vasodilatory effect on the cerebral 
vasculature.  Thus, the reason for the increase in CBF observed in the group of awake 
subjects could be due to a reflex of the sympathetic nervous system.  That is, the increase 
in CBF in the awake patients may be possibly due to a “fight-or-flight” response induced 
from the patient experiencing the drop in blood pressure caused by adenosine.  
Supporting this hypothesis is the difference in the change in heart rate due to adenosine 
seen between these two groups.  The group of patients that were awake during the 
adenosine infusion had, on average, an increase in heart rate due to the infusion, whereas 
patients who were anesthetized did not.  This suggests that the increase in heart rate is not 
due to the drug alone and may be influenced by the patient’s awareness of the drug and 
thus caused by a sympathetic response. 
Since CBF was observed to decrease due to adenosine in the subset of patients 
who were anesthetized, one could conclude that the primary effect of adenosine is 
actually to decrease CBF.  Further investigations, specifically into the interaction with 
anesthetics, are needed to definitively elucidate the effect of adenosine on cerebral 
vasculature. 
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4.6.5 Conclusion 
We observed that the effect of adenosine on cerebral blood flow depends on 
whether or not the patient is awake or anesthetized during the infusion.  Specifically, the 
adenosine infusion caused an increase in cerebral blood flow in patients when they were 
awake and a decrease in cerebral blood flow in anesthetized patients.  This result suggests 
that the increase in CBF observed in awake patients is due to a sympathetic response and 
not due to vasodilation of the cerebral vasculature driven by adenosine.  Although the 
evidence herein suggests that the primary effect of adenosine on cerebral vasculature is a 
decrease in CBF, further investigation is necessary to understand the role of drug 
interactions between adenosine and the anesthetics. 
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5 Diffuse Optical Measurements of Cerebral Oxygen 
Metabolism 
While DOS and DCS are both valuable tools on their own, together they can 
provide even greater insight into the health or impairment of the cerebral vasculature.  In 
this chapter, I first describe the hybrid DOS/DCS instrument that I assembled and 
troubleshot for use in the work presented in this thesis.  I then describe the theory behind 
using both of these techniques to measure cerebral oxygen metabolism.  I also describe 
work that I have done in validating measurements of cerebral oxygen metabolism in 
infants with CHD.  Finally, I demonstrate the clinical usefulness of a hybrid DOS/DCS 
device by describing a clinical study in which I use this hybrid instrument to measure 
cerebral oxygen metabolism in children with pulmonary hypertension.  
5.1 Hybrid DOS/DCS Instrumentation 
I combined the DOS module (Imagent, ISS Inc., Champagin, IL, see Section 2.4) and the 
DCS module (See Section 4.3) onto one portable cart and used them in tandem. Figure 20 
shows the hybrid device that was used for all results reported herein.3  One computer was 
used to control both devices.  However, the devices were controlled via two separate user 
interfaces.  The DCS module is operated with an in-house developed Labview program.  
This program controls a data acquisition (DAQ) module, which controls the laser’s power 
source. The DOS module is controlled by a data acquisition software developed by ISS 
                                                
3 Two similar devices were used interchangeably. There were no practical differences 
between these two devices that affect any of the work presented herein. 
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called Boxy. This software allows for real-time analysis of 𝜇! and 𝜇!′ to ensure adequate 
data quality. 
 
 
Figure 20: Hybrid DOS/DCS module used for the work presented in this thesis. 
 
5.2 Calculation of Cerebral Metabolic Rate of Oxygen 
In addition to the advantage of using DOS to measure the optical properties to 
improve the fitting and thus accuracy of our DCS measurements, valuable information is 
obtained when measuring CBF and StO2 concurrently, because one can then quantify the 
cerebral metabolic rate of oxygen (CMRO2). CMRO2 can be calculated using Fick’s 
equation: 
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T 𝐶𝑀𝑅𝑂! = 𝑂𝐸𝐹×𝐶𝐵𝐹×𝐶𝑎𝑂!. ((5.1) 
Here, OEF is again oxygen extraction fraction (see Section 2.5), CBF is cerebral blood 
flow, and CaO2 the arterial oxygen concentration which can be calculated using the 
formula: 
T 𝐶𝑎𝑂! = 1.39×𝑆𝑎𝑂!× 𝐻𝑔𝑏 + 0.003×𝑃𝑎𝑂!. ((5.2) 
Here, 1.39 is the amount of oxygen in milliliters that a fully saturated gram of 
hemoglobin can carry; 𝑃𝑎𝑂! is the partial pressure of oxygen in arterial blood, which is 
measured from an arterial blood gas and has units of mmHg; and again 𝑆𝑎𝑂! is the 
arterial oxygen saturation and 𝐻𝑔𝑏  is the hemoglobin concentration of arterial blood in 
units of grams per deciliter. CaO2 has units of milliliters of O2 per deciliter of blood.  
Equation 5.1 yields CMRO2 in units of milliliters of O2 per minute per 100 g of tissue.  
  Because DCS yields a BFI in units of cm2/s, instead of CBF in traditional units of  
(mL/min/100 g of tissue), the quantification of oxygen metabolism reported in this thesis 
is an index of CMRO2 denoted herein as CMRO2,i.  CMRO2,i has units of mL/dL×cm2/s 
and can be calculated form the formula: 
T 𝐶𝑀𝑅𝑂!,! = 𝑂𝐸𝐹×𝐵𝐹𝐼×𝐶𝑎𝑂!. ((5.3) 
Recall from Section 2.5, 𝑂𝐸𝐹 = !"!!!!"!!!"!! . If DOS data is acquired at a fast enough rate 
and the SNR is sufficient, then SvO2 can be calculated from the optical signal detected by 
DOS (see Chapter 3).  Thus, the resulting formula for 𝐶𝑀𝑅𝑂!,! is: 
 𝐶𝑀𝑅𝑂!,! = !"!!!!"!!!"!  !"!! ×𝐵𝐹𝐼×𝐶𝑎𝑂!. ((5.4) 
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When 𝑆𝑣𝑂!!"# cannot be determined, 𝐶𝑀𝑅𝑂!,! can be calculated from the following 
equation: 
 𝐶𝑀𝑅𝑂!,! = !! !"!!!!"!!!"!! ×𝐵𝐹𝐼×𝐶𝑎𝑂!, ((5.5) 
where, again, 𝛾 is the percentage of blood in the venous compartment and assumed in this 
work to be 𝛾 = 0.75.  This assumption may be problematic, since 𝛾 may vary 
significantly from patient to patient or even over time for individual patients. For the 
majority of the work presented in this thesis, CMRO2,i is calculated from this equation.  
5.3 Validation Studies 
In the same study discussed in Section 4.5, we validated CMRO2,i measured by 
optics against CMRO2 measured by MRI in a subset of the population reported in this 
thesis of infants with congenital heart disease [14].  In this study, CMRO2,i from optics 
was calculated from Equation 5.5.  CMRO2 measured by MRI was calculated using CBF 
and SvO2 measured in the superior sagittal sinus via VENC-MRI and MR susceptometry, 
respectively.  Arterial blood gases were used to calculate CaO! and SaO!, and thus the 
same values were used for the calculations of both CMRO2,i and CMRO2.  We observe a 
significant correlation between the two methods of measuring oxygen metabolism 
(𝑅! = 0.31;   p = 0.01). 
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Figure 21: Correlation of CMRO2,i measured with optics and CMRO2 measured with 
MRI. The black line denotes the line of best fit to the data (R2=0.31, p=0.01). 
 However, as stated in Section 4.5, BFI depends significantly on 𝜇!′.  Since BFI is 
used for calculating CMRO2,i, choosing to use the measured value of 𝜇!′ or an assumed 
value will also affect the validation of CMRO2,i.  When using BFI values calculated from 
assuming a single value of 𝜇!′ for all patients, the correlation and significance improve  
(𝑅! = 0.69;   𝑝 < 0.0001) (Figure 22). However, the values of CMRO2,i reported in 
Section 6 of this thesis were derived from BFI that is calculated using the individual 
subject’s measured 𝜇!′. 
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Figure 22: Comparison of CMRO2,i calculated using various values of 𝝁𝒔′ to CMRO2 
measured with MRI. Each set of data has a line of best fit.  The correlation between 
CMRO2,i and CMRO2 improves when an assumed value of 𝝁𝒔′ is used for calculating 
BFI.  
5.4 Cerebral hemodynamics in children with pulmonary hypertension 
5.4.1 Introduction 
Pulmonary hypertension (PH) is a rare condition in which patients exhibit a 
reduction in pulmonary blood flow and an inability of the pulmonary vasculature to 
dilate.  Currently, the severity of PH and the efficacy of treatment is assessed via invasive 
cardiac catheterization.  This procedure evaluates pulmonary and systemic vascular 
resistance and blood flow during a baseline condition and during two conditions that are 
chosen to challenge the vaso-reactivity of the vessels in the lungs.   
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In the first condition, the inspired air is augmented with 40 parts per million 
inhaled nitric oxide (iNO), which acts as a local vasodialator of the pulmonary arterioles. 
iNO is not believed to have any significant extra-pulmonary effects due to its rapid 
degradation upon inhalation. There have been reports of iNO therapy mitigating some 
neurological complications, such as cerebral palsy, in premature neonates [59, 60], 
suggesting that iNO could have effects on cerebral vasculature under certain conditions.   
  In the second condition, while maintaining the iNO concentration of 40ppm, the 
inspired room air is replaced by 100% oxygen (O2), which also acts as a pulmonary 
vasodilator.  However, 100% O2 is non-selective and has cerebral and systemic effects.  
Specifically, hyperoxia causes cerebral and systemic vasoconstriction in normal 
physiology and thus results in a decrease in CBF by approximately 10% [61, 62]. The 
goal of this investigation was to begin to explore the complex relationship between 
cerebral protective functions and diminishing lung function through quantification of 
cerebral metabolic rate of oxygen (CMRO2) in patients with pulmonary hypertension 
during these conditions. 
5.4.2 Methods 
Study Protocol 
This study was approved by the Children’s Hospital of Philadelphia Institutional 
Review Board.  All patients undergoing the cardiac catheterization protocol for pediatric 
pulmonary hypertension were evaluated for study inclusion.  After induction of 
anesthesia with Sevoflurane, we placed the optical probe on one side of the forehead and 
secured with an elastic bandage for the duration of the cardiac catheterization.  The 
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optical probe housed fibers for both DOS and DCS and had multiple source-detector 
separations for DOS (Figure 23).  After this probe was secured on the patient’s forehead, 
the cardiac catheterization commenced, starting with a baseline (room air) condition.  A 
general timeline of the study is shown in Figure 24. 
 
 
Figure 23: Picture of optical probe that combines optical fibers for DOS and DCS. 
 
 
Figure 24: Timeline of study.  The entire catheterization lasts approximately 90 minutes.  
The colored regions denote the times over which the optics data were averaged to 
calculate the effects of iNO and iNO+100% O2. 
 
Data Analysis 
Vital sign data were captured from clinical monitors using the Moberg CNS 1000 
monitor (Moberg, Ambler, PA, USA).  Optical data was acquired continuously 
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throughout the duration of the cardiac catheterization at a frame rate of approximately 0.3 
Hz. µμ!, µμ!′ and BFI were quantified every frame (see Sections 2.2 and 4.2). The relative 
change in CBF (rCBF) due to 40ppm iNO was quantified by comparing an average BFI 
during the baseline room-air period to an average at the end of the 40ppm iNO condition 
from the following formula:   
T 𝑟𝐶𝐵𝐹 = !"# During!"# Pre ×100%. ((5.6) 
Here, 𝐵𝐹𝐼 Pre denotes an average of BFI over 2 minutes immediately before the iNO 
was turned on and 𝐵𝐹𝐼 During denotes an average of BFI over 2 minutes at the end of the 
iNO period (i.e., immediately before the addition of 100% O2). The change in CBF due to 
100% O2 was also calculated using Equation 5.6, where 𝐵𝐹𝐼 Pre is the average BFI over 
2 minutes immediately before the O2 was increased from room air to 100% and 𝐵𝐹𝐼 During is the average BFI over 2 minutes immediately before the end of the 
catheterization. 
Similarly, changes in StO2 due to iNO and 100% O2 were calculated from the 
following formula: 
T Δ𝑆𝑡𝑂! = 𝑆𝑡𝑂! During − 𝑆𝑡𝑂! Pre. ((5.7) 
Here,    Pre and    During have the same meaning as defined for Equation 5.6.  Relative 
changes in CMRO2 (rCMRO2) due to iNO and 100% O2 were calculated from the 
following formula: 
T 𝑟𝐶𝑀𝑅𝑂! = 𝑟𝐶𝐵𝐹×𝑟𝑂𝐸𝐹×𝑟𝐶𝑎𝑂!, ((5.8) 
where 𝑟𝐶𝐵𝐹 is defined from Equation 5.6, 𝑟𝑂𝐸𝐹 = !"# During!"# Pre , and 𝑟𝐶𝑎𝑂! = !"!! During!"!! Pre .  
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Again,    Pre and    During have the same meaning as defined for Equation 5.6 
5.4.3 Results 
A total 29 patients have been studied so far.  The average age was 6.2±5.0 years 
and 16/29 of the patients were female.  We observed a significant increase in StO2 due to 
the change from 40 ppm iNO to 40ppm iNO + 100% O2 and a trend towards decreasing 
StO2 due to the change from room air to 40ppm iNO (Figure 25).  We observed opposite 
trends in OEF (Figure 27).   We observed no change in CBF due to either condition 
(Figure 26).   Likewise, we observed no change in CaO2 (Figure 27). While we observed 
no change in CMRO2 due to the change from room air to 40ppm iNO, we observe a trend 
towards decreasing CMRO2 due to the change from 40 ppm iNO to 40ppm iNO to 100% 
O2 (Figure 27). 
 
Figure 25: Changes in StO2 due to 40ppm iNO (left) and due to the addition of 100% O2 
(right).  StO2 increases due to the addition of 100% O2. The red line denotes the median 
value; the blue square extends to the 25th and 75th percentiles; the whiskers extend to the 
most extreme data points that are not outliers; and the outliers are plotted as individual 
points. 
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Figure 26: Relative changes in CBF due to 40ppm iNO (left) and due to the addition of 
100% O2 (right).  We do not observe any change in CBF due to iNO or 100% O2. The red 
line denotes the median value; the blue square extends to the 25th and 75th percentiles; the 
whiskers extend to the most extreme data points that are not outliers; and the outliers are 
plotted as individual points. 
 
Figure 27: Relative changes in OEF (left), CaO2 (center), and CMRO2 (right) due to 
40ppm iNO (left box) and due to the addition of 100% O2 (right box).  We observe a 
trend of decreasing OEF and CMRO2 due to the addition of 100% O2. The red line 
denotes the median value; the blue square extends to the 25th and 75th percentiles; the 
whiskers extend to the most extreme data points that are not outliers; and the outliers are 
plotted as individual points. 
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5.4.4 Discussion 
The results of this study are still being vetted.  However, these preliminary results 
suggest that iNO and 100% O2 have a normal effect on CMRO2 in children with 
pulmonary hypertension.  In a study of healthy adults, Xu et al. observed that hyperoxia 
caused an increase in StO2, no change in CBF, and a slight decrease in CMRO2, similar 
to the results reported here [63].  Additionally, we did not observe any cerebral effects of 
iNO, which is expected for healthy cerebral vasculature.  However, this population of 
children with PH was highly heterogeneous with respect to severity of the disease and 
medications being used to treat the disease.  More patients need to be recruited to be able 
to separate out any effect that disease severity or treatment plans may have on these 
results.   
5.4.5 Conclusion 
Hybrid DOS/DCS is a useful tool for non-invasively quantifying CMRO2 at a 
patient’s bedside, or in this case in a catheterization suite.  We have shown that these 
measurements are possible in this population, for which CMRO2 had not been previously 
measured.  These initial results suggest that the cerebral responses to these clinical 
interventions and perturbations of the pulmonary vasculature may be normal and similar 
to those seen in healthy adults. 
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6 Investigating risks for brain injury in infants with critical 
CHD 
In this chapter, I describe a clinical investigation using DOS and DCS to 
determine the risk factors for brain injury in infants with CHD.  The results in Section 
6.4.2 have recently been submitted for publication [16], and the results in Sections 6.4.1 
and 6.4.3 are currently being prepared for publication. 
6.1 Introduction 
Approximately 30,000 children each year are born in the United States with 
congenital heart disease (CHD).  Nearly one third of these CHD patients require cardiac 
surgery in their first few months of life [1]. With the improved survival from these early 
surgeries, the majority of these patients are now reaching school age [64], the focus of 
research has shifted to addressing the neurodevelopment difficulties seen among these 
survivors. Nearly 50% of the school-age survivors exhibit some neurobehavioral 
symptoms, such as inattention, hyperactivity, and impaired executive function [2, 65, 66].  
        Neonatal imaging and neuropathologic studies of patients with complex 
CHD undergoing infant surgical intervention have revealed a high prevalence of 
periventricular leukomalacia (PVL) [7]. PVL is a specific form of hypoxic-ischemic 
white matter injury that commonly occurs in a vascular watershed zone near the lateral 
ventricles (Figure 28); it is most often observed in preterm neonates who have 
neurodevelopmental outcomes remarkably similar to those of term patients with CHD. 
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Figure 28: Example of MR image depicting an infant brain with PVL. (Left) Sample T1-
weighted MR image of infant brain.  (Right) The same image, with the results of a 
manual segmentation of PVL volumes shown in color. 
To date, clinical investigations in CHD neonates have focused on identifying the 
pre-, peri-, and post-surgical risk factors linked to PVL in order to mitigate or prevent this 
injury, but uncertainties about its exact cause and timing remain [67-69].  These previous 
studies have identified possible risk factors for this injury such as abnormal or delayed 
brain maturation, duration of deep hypothermic circulatory arrest during surgery, and 
post-operative cerebral oxygenation [9, 67, 70]. However, most of these studies have 
been carried out in mixed cohorts.  In this chapter, I discuss the results from an 
investigation of a large cohort of neonates with CHD, allowing me to focus on risk 
factors specific to individual diagnoses. Utilizing diffuse optical and diffuse correlation 
spectroscopies (DOS and DCS, respectively) for non-invasive bedside quantification of 
pre- and post-operative cerebral hemodynamics [18, 71], I explore the relationship of 
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these parameters and other pre-operative, operative, and post-operative variables to the 
risk of developing PVL.  
6.1.1 Physiology of a healthy heart 
In order to understand the significance of the impaired physiology of either HLHS 
or TGA, one must first understand the anatomy of the healthy heart.   
 
Figure 29: Schematic diagram of a healthy heart.   
A normal heart has four chambers: the left ventricle, right ventricle, left atrium and right 
atrium (Figure 29). Oxygen-poor blood from the body enters the right atrium via the 
superior and inferior vena cava.  From there it travels to the right ventricle, through the 
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tricuspid valve and then, via the pulmonary valve and artery, into the lungs to become 
oxygenated.  From the lungs, it reenters the heart by traveling through the pulmonary 
veins and into the left atrium.  From the left atrium, the blood travels through the mitral 
valve into the ascending aorta to deliver oxygenated blood to the systemic circulation, 
including the brain. 
6.1.2 Hypoplastic Left Heart Syndrome 
Description of defect 
Hypoplastic left heart syndrome (HLHS) is one of the most severe and common 
critical CHD, making up approximately 9% of critical CHD cases [72]. In this disorder, 
the left ventricle is critically underdeveloped by a lack of blood flow through either a 
maldeveloped mitral or aortic valve.  Therefore, the right ventricle, which is normally 
responsible for pumping deoxygenated blood to the lungs, must pump blood to the body 
and brain as well as the lungs.  Blood gets to the systemic circulation via the ductus 
arteriosis, a developmental artery that connects the common pulmonary artery to the 
descending aorta.  At birth, the ductus arteriosis receives signal to close as a result of 
infant lungs filling with air for the first time.  A medication, called prostaglandin, is given 
to the baby to hold the ductus arteriosis open.  Even with this medication, if left 
untreated, HLHS is fatal within the first week or two of life.  Palliative cardiac surgery is 
performed usually in 3 stages to treat HLHS by transforming the right ventricle into the 
systemic ventricle (left ventricle equivalent) and allow the lungs to receive blood from 
the vena caval system passively (i.e., without going through the heart).  During the first 
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week of life, neonates with HLHS undergo the first stage, the Norwood procedure [72].  
All infants with HLHS described in this thesis undergo this operation.   
Previous findings on neurodevelopmental outcome 
As described in Section 1.2, there are significant neurodevelopmental symptoms 
that are associated with HLHS.  Mahle et al. focused specifically on this cohort, and 
through a questionnaire filled out by parents, found that approximately 1/3 of children 
with HLHS were receiving some form of special education [4].  This study also found 
that median IQ was 86 (below average), and that 18% of patients had mental retardation 
(defined as an IQ < 70).  Believed to be the underlying cause of these symptoms is the 
high prevalence of PVL seen in this cohort [7].   
As seen in this cohort, as well as in previous studies of infants with HLHS, the 
majority of PVL seen in this cohort is on post-operative MRI scans (see Section 6.4) [16, 
70, 73].  Work has been done to identify the risk factors for PVL, however most of this 
work has been mostly carried out in mixed populations of neonates with various CHDs 
(including HLHS) and has not been verified in homogenous populations of infants with 
HLHS [9, 67]. Andropoulus et al. reported brain maturation to be the primary risk for 
both pre- and post-operative PVL in a mixed cohort of neonates undergoing cardiac 
surgery with hypothermic cardiopulmonary bypass for 60 minutes or greater [67]. Beca et 
al. reported duration of DHCA and brain maturation to be significantly associated with 
post-operative PVL in a mixed cohort of infants undergoing surgery with arch 
reconstruction [9]. In a homogeneous population of infants with HLHS, Dent et al. 
reported that having a post-operative cerebral oxygenation, measured with commercial 
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NIRS, less than 45% for at least 180 min was significantly associated with post-operative 
PVL [70].  This finding was not replicated later in a mixed population by Andropoulus et 
al [67].   
6.1.3 Transposition of the Great Arteries 
Description of defect 
Transposition of the great arteries (TGA) is another common critical CHD and 
slightly more prevalent than HLHS [74]. In TGA, the pulmonary artery, which carries 
oxygen-poor blood from the heart to the lungs, and the aorta, which carries oxygen-rich 
blood from the heart to the body, are transposed.  Therefore, left uncorrected, oxygen-
poor blood will continue to cycle through the body without returning to the lungs to 
become oxygenated.  Following birth, a balloon atrial septostomy is performed in some 
patients, which opens a connection between the right and left atrium, allowing mixing of 
oxygen-rich and oxygen-poor blood while the baby waits for their corrective surgery. 
Previous findings on neurodevelopmental outcome 
 As with HLHS and other CHD, TGA is associated with neurodevelopmental 
dysfunction later in life (see Section 1.2).  The Boston Circulatory Arrest Study 
investigated the outcomes of 139 16-year-old children with TGA who underwent 
corrective surgery as infants [65].  Again, there was a high use of ancillary educational 
services (65%), which included tutoring (37%), grade retention (17%), early intervention 
(19%), occupational therapy (23%), full-time special education classroom (25%), and 
counseling (25)%.  
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As seen in the cohort presented herein as well as in previous cohorts of infants 
with TGA, the highest incidence of PVL seen in these patients is on pre-operative MRI 
scans (see Section 6.4) [10, 75, 76].  Petit et al. investigated risk factors for this pre-
operative PVL, and found that time-to-surgery and pre-operative arterial oxygenation 
[10].  This work was the first to suggest that, at least in infants with TGA, earlier surgery 
may mitigate the risk for developing PVL.  Anderson et al. recently augmented these 
findings in a retrospective study showing that earlier surgery in infants with TGA was 
associated with less major morbidity, including seizure and stroke [77]. 
 
6.2 Study Protocol 
All procedures were approved by the Institutional Review Board at CHOP. 
Patients with complex congenital heart were included in this study.  Patient demographic 
data, including time of birth, gestational age, birth weight, head circumference on day of 
surgery, gender and cardiac diagnosis, were recorded. A timeline of the study is presented 
in Figure 30. On the morning of surgery, all patients received general anesthesia (fentanyl 
5-10 µg/kg, pancuronium 0.2mg/kg) with endotracheal intubation. Subsequently, they 
underwent a brain MRI for pre-operative injury assessment. Pre-operative DOS/DCS 
measurements of cerebral oxygenation (StO2) and blood flow index (BFI) were also made 
at this time.  
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Figure 30: Timeline of study of infants with CHD. 
After the MRI, patients underwent surgery.  All surgery was performed under 
cardiopulmonary bypass with some diagnoses requiring deep hypothermic circulatory 
arrest (DHCA) for aortic arch repair (see Section 6.3).  To achieve DHCA, patients 
underwent core and surface cooling to a nasopharyngeal (NP) temperature of 18°C, at 
which point the bypass machine is stopped and the bypass cannulas are removed from the 
surgical field.   Antegrade cerebral perfusion was not used as it is at some other centers.  
The surgeries were either corrective or palliative, depending on the diagnosis (see Section 
6.3). Operations were performed by one of four cardiac surgeons. pH-stat blood gas 
management was used to adjust for gas solubility at lower temperatures. Modified 
ultrafiltration was performed in all patients after CPB. Commercial cerebral oximetry was 
not used to guide intraoperative or post-operative management. Surgical strategy 
included sternal closure where tolerated. 
After surgery, the patients were transported back to the cardiac intensive care unit 
(CICU). Post-operative StO2 and CBF were quantified every 2 hours for the first 12 hours 
during recovery in the CICU.  Approximately 1 week after surgery, patients underwent a 
post-operative follow-up MRI scan to assess the development and/or progression of brain 
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injury.   
6.2.1 Brain MRI 
All images were acquired on a 1.5T Avanto MRI system (Siemens Medical 
Systems, Malvern, NJ, USA) using a 12-channel head coil. Studies included T1 
MPRAGE (Magnetization-Prepared Rapid Acquisition Gradient Echo) and T2 SPACE 
(Sampling Perfection with Application-optimized Contrasts using different flip angle 
Evolution). All sequences were acquired in the axial plane and were later reconstructed in 
the sagittal and coronal planes. Susceptibility sequences (susceptibility weighted 
imaging, SWI), and diffusion weighted imaging (DWI) sequences were also acquired. 
The presence of PVL was assessed from T1 sequences in conjunction with DWI in both 
the pre- and post-operative scans.  Manual segmentation of the T1 hyperintense lesions 
were performed using ITK-SNAP [78] and were used to calculate PVL volumes. New or 
worsened PVL was calculated by the difference in PVL volume between the post and 
pre-operative scans. In addition to PVL classification, two independent observers blinded 
to clinical data evaluated brain maturation by quantifying a total maturation score (TMS) 
using axial T1 and T2 images [79, 80]. 
6.2.2 DOS/DCS Measurements 
DOS and DCS measurements were conducted once pre-operatively, once post-
operatively immediately after return to the CICU, and then once every 2 hours for the 
subsequent 12 hours.  For statistical analysis of post-operative measurements, we 
included only the initial value of StO2 and BFI upon return to the CICU and the lowest 
measured post-operative value of StO2. Measurements were made over both the right and 
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left frontal cortex.  At each location, four repetitions were acquired in order to account 
for local inhomogeneities under the optical probe.  These 8 repetitions were then 
averaged together to derive a global measure of StO2 and BFI.  Optical data measured 
with DOS and DCS, i.e., StO2, and BFI, were acquired on only a subset of patients due to 
a change in protocol that used improved optical instrumentation and allowed for these 
optical measurements partway through enrollment.   
6.2.3 Statistical Analysis 
Continuous variables were summarized by standard descriptive statistics (mean, 
standard deviation (SD), and median, interquartile range (IQR) as appropriate), and 
frequencies and percentages for categorical variables. Continuous variables were 
compared between groups by employing Wilcoxon rank-sum tests.  
6.3 Patient population 
At the time of writing this thesis, we have recruited a total of N=98 subjects under 
the protocol described in Section 6.2.  Three of these subjects were consented but not 
studied due to availability of the MRI on the morning of the scheduled surgery.  All 
subjects were full term and medically stable for at least 24 hours prior to the day of 
surgery.  Our study protocol excluded recruitment of any infant born prematurely (< 37 
week gestational age), infants with neonatal depression, infants who are small for their 
gestational age (< 2 kg), infants who had perinatal seizures, infants who displayed 
evidence of other end-organ injury, infants who had pre-operative cardiac arrest acquiring 
chest compression, and any infant with significant intracerebral hemorrhage.   
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The majority of the subjects that were studied (N=95) were diagnosed with either 
hyperplastic left heart syndrome (N=46) or transposition of the great arteries (N=32).  
The remaining subjects had the following primary diagnoses: Tetralogy of Fallot (N=5), 
heterotaxy (N=1), coarctation of the aorta (N=1), aortic stenosis (N=1), tricuspid atresia 
(N=1), double-inlet left ventricle (N=1), hypoplastic arch (N=2), pulmonary atresia 
(N=1), ventricular septal defect ( N=1), and interrupted aortic arch (N=3).  
Table 6: Description of groups used to categorize subjects. 
 Palliative or Corrective 
DHCA or 
No DHCA Diagnoses Included 
Group 1 Palliative DHCA HLHS, HLHS variants, Tricuspid Atresia, DILV 
    
Group 2 Corrective No DHCA TGA, ToF, Heterotaxy 
    
Group 3 Palliative No DHCA PA  
    
Group 4 Corrective DHCA CoA, Aortic Stenosis, Hypoplastic Arch, IAA, VSD 
 DHCA, Deep Hypothermic Circulatory Arrest; HLHS, Hypoplastic Left Heart Syndrome; 
DILV, Double Inlet Left Ventricle; VSD, Ventricular Septal Defect; TGA, Transposition 
of the Great Arteries; ToF, Tetralogy of Fallot; PA, Pulmonary Atresia; CoA, Coarctation 
of Aorta; IAA, Interrupted Aortic Arch 
Due to the large number of diagnoses and the limited number of subjects recruited 
with each diagnosis (other than TGA and HLHS), we group similar diagnoses together.  
We define four groups based on whether or not the surgery the patient undergoes is 
palliative or corrective and whether or not the surgery is done under DHCA.  A 
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description of thee groups appears in Table 6. The demographic data for these subjects 
are reported Table 7. 
Table 7 Demographic data for the infants with CHD studied.  All continuous variable are 
listed as mean ± standard deviation. 
Group N Female (n) 
Age at 
Surgery 
(days) 
Gestational 
Age  
(weeks) 
Birth 
Weight 
(kg) 
Head 
Circumference 
Group 1 48 20 4.0±1.8 39.0±0.8 3.4±0.5 34.2±1.3 
Group 2 37 15 3.9±1.8 38.9±1.0 3.6±0.5 34.5±1.0 
Group 3 1 0 2.0 37.1 3.1 34.0 
Group 4 9 6 6.3±4.1 38.6±1.3 3.2±0.6 33.8±1.5 
All 95 41 4.2±2.2 38.9±0.9 3.4±0.5 34.3±1.2 
 
6.4 Results 
Not all of the optical measurements described in Section 6.2 were made on all 95 
subjects.  This was due to either data quality or availability of the optical instrument, 
optical probes, or personnel on the day of surgery.  Pre-operative variables measured with 
optics on the morning of surgery are listed in Table 8, with averages given for each group 
of subjects. Variables include total hemoglobin concentration (THC, in units of µM), 
cerebral tissue oxygen saturation (StO2), cerebral blood flow index (BFI, in units of 
cm2/s), oxygen extraction fraction (OEF), and an index of cerebral metabolic rate of 
oxygen (CMRO2,i, in units of ml/dl × cm2/s).  The same variables, measured immediately 
upon return to the cardiac intensive care unit (CICU) from surgery are reported in Table 
9. 
 79 
Table 8: Preoperative optical variables for all infants with CHD studied.  Values are 
reported as mean ± standard deviation.  Not all measurements were conducted on all 
subjects. The number in brackets represents the number of subjects with that measured 
parameter. 
Group THC (µM) 
StO2 
(%) 
BFI 
(108 cm2/s) OEF 
CMRO2,i 
(10-7 ml/dl × cm2/s) 
Group 1 
N=48 
38.1±11.5 
[39] 
46.0±11.7 
[39] 
2.6±1.6 
[37] 
0.47±0.14 
[33] 
1.6±1.4 
[32] 
      
Group 2 
N=37 
38.2±7.9 
[25] 
51.0±9.9 
[25] 
3.3±2.1 
[24] 
0.38±0.12 
[22] 
1.6±1.1 
[21] 
      
Group 3 
N=1 
37.1 
[1] 
63.9 
[1] 
2.5 
[1] 
0.27 
[1] 
0.8 
[1] 
      
Group 4 
N=9 
47.3±18.2 
[9] 
56.0±13.1 
[9] 
1.3±0.6 
[9] 
0.33±0.10 
[7] 
0.6±0.4 
[6] 
      
All 
N=95 
39.4±11.6 
[74] 
49.1±11.7 
[74] 
2.7±1.8 
[71] 
0.42±0.14 
[63] 
1.5±1.3 
[60] 
THC, Total Hemoglobin Concentration; StO2, Cerebral Tissue Oxygen Saturation; BFI, 
Blood Flood Index; OEF, Oxygen Extraction Fraction; CMRO2,i, Cerebral Metabolic 
Rate of Oxygen 
 
One goal of this study was to investigate the difference in post-operative cerebral 
hemodynamics between these four different groups who underwent significantly different 
cardiac surgeries and, as we are learning, also display significantly different incidences of 
PVL (Table 10). However, at the time of writing this thesis, we have not recruited enough 
subjects for Groups 3 or 4 to perform an adequate analysis on the differences between 
these four groups.  Therefore, the remainder of this Section will focus exclusively on 
infants with HLHS and TGA. 
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Table 9: Postoperative optical variables for all infants with CHD studied.  Values are 
reported as mean ± standard deviation. Not all measurements were conducted on all 
subjects. The number in brackets represents the number of subjects with that measured 
parameter. 
Group THC (µM) 
StO2 
(%) 
BFI 
(108 cm2/s) OEF 
CMRO2,i 
(10-7 ml/dl × cm2/s) 
Group 1 
N=48 
71.1±14.5 
[35] 
41.5±7.0 
[35] 
2.0±1.6 
[31] 
0.43±0.11 
[33] 
1.3±1.3 
[29] 
      
Group 2 
N=37 
58.9±15.3 
[26] 
55.0±11.2 
[26] 
2.5±1.6 
[26] 
0.44±0.11 
[23] 
1.7±1.1 
[23] 
      
Group 3 
N=1 
71.3 
[1] 
59.8 
[1] 
3.9 
[1] 
0.11 
[1] 
0.5 
[1] 
      
Group 4 
N=9 
69.0±25.9 
[8] 
52.0±6.9 
[8] 
1.8±2.1 
[8] 
0.47±0.09 
[7] 
1.2±1.3 
[7] 
      
All 
N=95 
66.3±17.0 
[70] 
48.0±10.8 
[70] 
2.2±1.6 
[66] 
0.44±0.11 
[64] 
1.4±1.2 
[60] 
THC, Total Hemoglobin Concentration; StO2, Cerebral Tissue Oxygen Saturation; BFI, 
Blood Flood Index; OEF, Oxygen Extraction Fraction; CMRO2,i, Cerebral Metabolic 
Rate of Oxygen 
 
Table 10 summarizes the results of the volumetric amount of PVL from the pre- 
and post-operative MRI scans on all N=95 subjects.  One can see from this table that 
there is significant variation between the different groups (see Section 6.4.1).   The rest of 
this Section will delve into predictive risk factors for this PVL in infants with HLHS and 
TGA. 
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Table 10: Pre-operative and post-operative volumes of PVL averaged over the four 
different groups of patients.  Continuous variables are reported mean ± standard deviation 
and incidence of PVL is reported as N (%).The volumetric amount represents the 
average, non-zero volume of PVL. 
 Pre-Operative Post-Operative 
Diagnosis PVL N (%) 
Volume 
(mm3) 
MRI 
N (%) 
PVL 
N (%) 
Volume 
(mm3) 
Group 1 
N=48 
9 
(19.2%) 223.3±288.1 
42 
(87.5%) 
31 
(73.8%) 833.9±1637.6 
      
Group 2 
N=37 
7 
(18.9%) 190.7±361.9 
35 
(94.6%) 
7 
(20.0%) 179.4±398.5 
      
Group 3 
N=1 
1 
(100%)  16.9 
1 
(100%)  
1 
(100%) 37.5 
      
Group 4 
N=9 
2 
(22.2%) 8.5±2.2 
8 
(88.9%) 
4 
(50.0%) 107.9±70.3 
      
      
All 
N=95 
19 
(20.2%) 175.3±293.8 
86 
(90.5%) 
43 
(50.0%) 641.3±1427.3 
 
6.4.1 Differences between HLHS and TGA 
We have studied a total of N=78 patients with either HLHS (N=46) or TGA 
(N=32).  The demographic data for these 78 patients are described in Table 11. 
Table 11: Patient demographics for all infants with HLHS and TGA. 
Group N Female (n) 
Age at 
Surgery 
(days) 
Gestational 
Age  
(weeks) 
Birth 
Weight 
(kg) 
Head 
Circumference 
HLHS 46 20 4.0±1.9 39.0±0.8 3.4±0.5 34.2±1.4 
TGA 32 12 3.5±1.2 38.9±1.0 3.5±0.5 34.4±1.0 
All 78 32 4.8±1.6 38.9±0.9 3.4±0.5 34.3±1.2 
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Table 12: Pre-operative and post-operative volumes of PVL averaged over the 
population of infants with HLHS and infants with TGA.  Continuous variables are 
reported as mean ± standard deviation and incidence of PVL is reported as N (%).  The 
volumetric amount represents the average, non-zero volume of PVL. 
 Pre-Operative Post-Operative 
Diagnosis PVL N (%) 
Volume 
(mm3) 
MRI 
N (%) 
PVL 
N (%) 
Volume 
(mm3) 
HLHS 
N=46 
9 
(20.0%) 223.3±288.1 
40 
(87.0%) 
29 
(72.5%) 793.3±1647.8 
      
TGA 
N=32 
6 
(18.8%) 219.8±387.3 
30 
(93.8%) 
5 
(16.7%) 237.1±472.7 
      
All 
N=95 
15 
(19.5%) 221.8±320.0 
70 
(89.7)% 
34 
(48.6%) 711.5±1539.8 
 
As was briefly mentioned earlier in this Section, we see a difference in the 
incidence of PVL between these two diagnoses.  Table 12 summarizes the incidence and 
volumetric amount of PVL seen in infants with HLHS and TGA both pre- and post-
operatively.   As is apparent from Table 12, there is a striking difference between these 
two groups in both the incidence of post-operative PVL and in the average non-zero 
volumetric amount.  To further illustrate this, Figure 31 shows a boxplot of post-
operative volumes separated by diagnosis.  Note, this figure includes patients who had a 
volume of 0 mm3 and several outliers had to be removed from the HLHS group for 
visualization purposes.  One can see that the median volume of post-operative PVL is 
significantly different between the two groups (p<0.00001; Wilcoxon Rank-sum).  
Therefore, infants with HLHS are at a much greater risk for injury than infants with 
TGA, and the majority of injury is seen on a post-operative, rather than pre-operative, 
MRI scan. 
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Figure 31: Boxplot of post-operative PVL volumes for infants with HLHS and TGA.   
Infants with HLHS have significantly more post-operative PVL than infants with TGA. 
The red line denotes the median value; the blue square extends to the 25th and 75th 
percentiles; the whiskers extend to the most extreme data points that are not outliers; and 
the outliers are plotted as individual points. 
We do not see a significant difference in volumetric amount or incidence of pre-
operative PVL between these two cohorts.  However, it is important to note that we 
observed less incidence of pre-operative PVL in infants with TGA than has been 
previously reported [10].  This may be due to the fact that the cohort studied by Petit et 
al. went to surgery an average of 1 day later than the population studied here.  This is 
likely due to change of practice as a result of the findings in the study by Petit at al. that 
show that shorter time-to-surgery could be preventative against pre-operative PVL [10]. 
To understand this observed difference in PVL between these two diagnoses, we 
investigated differences in both pre- and post-operative cerebral hemodynamics.  Table 
 84 
13 summarizes pre-operative optical variables. As you can see, these parameters are 
fairly similar between the two groups, which is further illustrated in Figure 32.   
Table 13: Pre-operative optical variables for infants with HLHS and TGA. Values are 
reported as mean ± standard deviation.  Not all measurements were conducted on all 
subjects. The number in brackets represents the number of subjects with that measured 
parameter. 
Group THC (µM) 
StO2 
(%) 
BFI 
(108 cm2/s) OEF 
CMRO2,i 
(10-7 ml/dl × cm2/s) 
HLHS 
N=46 
38.3±11.8 
[37] 
46.3±12.0 
[37] 
2.5±1.6 
[35] 
0.47±0.14 
[31] 
1.6±1.5 
[30] 
      
TGA 
N=32 
37.2±7.0 
[21] 
49.5±9.9 
[21] 
3.1±2.1 
[21] 
0.40±0.12 
[18] 
1.5±1.2 
[18] 
      
All 
N=78 
37.9±10.2 
[58] 
47.5±11.3 
[58] 
2.7±1.8 
[56] 
0.44±0.13 
[49] 
1.5±1.4 
[48] 
THC, Total Hemoglobin Concentration; StO2, Cerebral Tissue Oxygen Saturation; BFI, 
Blood Flood Index; OEF, Oxygen Extraction Fraction; CMRO2,i, Cerebral Metabolic 
Rate of Oxygen 
 
Table 14 summarizes post-operative optical variables measured upon immediate 
return to the CICU.  As is shown in Table 14, there is a significant difference between in 
post-operative StO2 and THC between these two groups.  This is illustrated in the box-
plots in Figure 33. 
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Table 14: Post-operative variables measured with optics. Values are reported as mean ± 
standard deviation.  Not all measurements were conducted on all subjects. The number in 
brackets represents the number of subjects with that measured parameter. 
Group THC (µM) 
StO2 
(%) 
BFI 
(108 cm2/s) OEF 
CMRO2,i 
(10-7 ml/dl × cm2/s) 
HLHS 
N=46 
71.8±14.0 
[34] 
41.2±6.7 
[34] 
1.9 ±1.6 
[30] 
0.44±0.11 
[32] 
1.3±1.3 
[28] 
      
TGA 
N=32 
58.0±15.3 
[22] 
55.6±11.2 
[22] 
2.3±1.5 
[21] 
0.43±0.11 
[20] 
1.4±0.7 
[19] 
      
All 
N=78 
66.4±15.9 
[56] 
46.8±11.2 
[56] 
2.1±1.5 
[51] 
0.44±0.11 
[52] 
1.3±1.1 
[47] 
THC, Total Hemoglobin Concentration; StO2, Cerebral Tissue Oxygen Saturation; BFI, 
Blood Flood Index; OEF, Oxygen Extraction Fraction; CMRO2,i, Cerebral Metabolic 
Rate of Oxygen 
 
 
Figure 32: Boxplot of pre-operative optical variables for infants with HLHS and TGA. 
Pre-operative optical variables are BFI (a), StO2 (b), OEF (c), CMRO2,i (d), THC (e). We 
observe no differences in any of these variables between infants with HLHS and TGA. 
The red line denotes the median value; the blue square extends to the 25th and 75th 
percentiles; the whiskers extend to the most extreme data points that are not outliers; and 
the outliers are plotted as individual points. 
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Figure 33: Boxplot of post-operative variables for infants with HLHS and TGA. Post-
operative variables are BFI (a), StO2 (b), OEF (c), CMRO2,i (d), THC (e). WE observe a 
significant difference in StO2 and THC between the two diagnoses.  The red line denotes 
the median value; the blue square extends to the 25th and 75th percentiles; the whiskers 
extend to the most extreme data points that are not outliers; and the outliers are plotted as 
individual points.   
The significant differences in post-operative StO2 THC, and PVL between infants 
with HLHS and TGA suggests that the high risk for post-operative PVL seen in HLHS is 
due to post-operative parameters. The next section focuses only on infants with HLHS to 
identify risk-factors for this high prevalence of PVL. 
6.4.2 Risk factors for PVL in HLHS 
The major result to come out of this work is on an investigation of the risk factors for 
PVL in infants with HLHS.  Of the N=46 neonates with HLHS that have been studied so 
far, post-operative MRIs were not acquired on 6 subjects due to the following reasons: 
four patients were deemed clinically unstable for a post-operative MRI during study 
period, one subject had a pacemaker placed and was thus unable to undergo an MRI, and 
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one subject was withdrawn from the post-operative MRI due to parental request.  Thus, 
both pre- and post-operative MRI scans were acquired on N=40 subjects.  Relevant 
clinical data was not currently available on the most recent 3 subjects, so the subsequent 
analysis was performed on N=37 neonates diagnosed with HLHS (n=30) or HLHS 
variants (n=7). The HLHS variants consisted of unbalanced atrioventricular canal (n=4), 
double outlet right ventricle (n=2), and mitral valve dysplasia and aortic valve stenosis 
(n=1), and all were associated with significant aortic arch hypoplasia. All patients were 
full term with an average gestational age of 38.9±0.8 weeks. Patient demographics and 
pre-operative and post-operative cerebral hemodynamics are described in Table 15. 
 
Figure 34:  Volumetric amount of pre- and new post-operative PVL in neonates with 
HLHS. The full bar represents the volume of PVL on post-operative scans, with the 
volume that was present on pre-operative scans shown in blue. Subjects are numbered in 
order of increasing change in PVL volume between pre- and post-operative MRI scans. 
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Table 15: Summary of demographic and pre- and post-operative cerebral hemodynamic 
variables measured for all subjects with HLHS. Continuous variables are presented by 
means ± standard deviation for continuous variables and frequencies (%) for categorical 
variables.   
TMS, Total Maturation Score; SaO2, arterial oxygen saturation; StO2, cerebral tissue 
oxygen saturation; BFI, Blood Flow Index; CBV, Cerebral Blood Volume; CMRO2,i, 
Index of Cerebral Metabolic Rate of Oxygen; CPB, Cardiopulmonary Bypass; DHCA, 
Deep Hypothermic Circulatory Arrest; NP, Nasopharyngeal. 
 
Figure 34 depicts the volumetric amount of PVL acquired pre- and post-
operatively in the 37 subjects studied herein.  Eight (21.6%) patients had pre-operative 
Time-to-surgery, days 4.2±1.9 
Time between MRI, days 7.1±2.8 
Gestational age, wk 38.8±0.8 
Birth weight, kg 3.3±0.5 
Head circumference, cm 34.0±1.4 
Female, n (%) 19 (51.4) 
Aortic Stenosis, n (%) 9 (27.3) 
TMS 9.9±0.9 
Pre-operative SaO2, % 90.0±5.2 
StO2, % 48.8±13.3 
BFI, 10-8 cm2/s  2.4±1.6 
CBV, mL/100g 2.1±0.5 
CMRO2,I, 10-7 ml/dl × cm2/s  1.6±1.4 
CPB time,  92.2±25.3 
DHCA time, min 44.8±9.7 
Lowest NP temperature,  17.8±0.9 
Number of bypass runs, n  1.1±0.4 
Delayed sternal closure, n (%) 5 (13.5) 
Cardiac arrest, n (%) 1 (2.7) 
Initial StO2, % 40.8±7.2 
Initial BFI, 10-8 cm2/s 1.5±0.7 
Initial CBV, mL/100g 3.9±0.7 
Initial CMRO2,i, 10-7 ml/dl × cm2/s  1.4±1.3 
Lowest StO2, % 35.0±9.4 
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and 28 (75.7%) had post-operative PVL.  Additionally, most subjects who had pre-
operative PVL acquired more post-operatively.  Therefore, we chose to focus on the 
difference between the volumes of PVL acquired post- and pre-operatively.  The 
distribution of this parameter is shown in Figure 35.  An increase in volume from pre- to 
post-operative PVL was observed in 26/37 (70.3%) of patients, and the acquired volume 
ranged from 2.5 mm3 to 7577.7 mm3.  As is apparent from Figure 35, the distribution of 
change in volume of PVL is highly skewed.  
 
Figure 35: Change in volume of PVL between pre- and post-operative MRI scans. The 
red line denotes the median value of change in PVL volume.  Subjects are numbered in 
order of increasing change in PVL volume. 
Because of the highly skewed distribution of change in PVL volumes in the 
present dataset, the outcome variable of new or worsened post-operative PVL was 
dichotomized around its median value.  Figure 36 illustrates an example of a large 
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volume (7577.7 mm3) versus a small volume (70.7mm3) of PVL. Table 16 give the pre- 
and post-operative and demographic data for those subjects with a large change in post-
operative PVL and those without or with a small amount. The group with a large amount 
of post-operative of PVL had a mean time-to-surgery of 5.3±1.5 days, compared with 
3.1±1.7 days for the no or small amount of PVL group (p=0.0003).  Further, patients with 
new or worsened post-operative PVL tended to have higher pre-operative BFI (p=0.05) 
and lower pre-operative StO2 (p=0.09). Of note, TMS, post-operative StO2, and DHCA 
duration were not significantly different between the two groups. 
 
Figure 36: An example of a small volume (left, 70.7 mm3) and a large volume (right, 
7577.7 mm3) of PVL. 
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Table 16: Summary of demographic and pre- and post-operative cerebral hemodynamic 
variables measured for subjects with and without new or worsened PVL > 76.3 mm3. 
Continuous variables are presented as means ± standard deviation for continuous 
variables and frequencies (%) for categorical variables.   
A Wilcoxon rank-sum test used to test differences between the two groups. (* significant, 
# marginally significant). TMS, Total Maturation Score; SaO2, arterial oxygen saturation; 
StO2, cerebral tissue oxygen saturation; BFI, Blood Flow Index; CBV, Cerebral Blood 
Volume; CMRO2,i, Index of Cerebral Metabolic Rate of Oxygen; CPB, Cardiopulmonary 
Bypass; DHCA, Deep Hypothermic Circulatory Arrest; NP, Nasopharyngeal. 
 
Variable PVL (n=18) 
No PVL 
(n=19) P 
Time-to-surgery, days 5.3±1.5 3.1±1.7 <0.001* 
Time between MRI, days 7.1±2.9 7.0±2.9 0.90 
Gestational age, wk 38.9±0.9 38.8±0.7 0.59 
Birth weight, kg 3.3±0.5 3.2±0.5 0.77 
Head circumference, cm 34.1±1.5 34.0±1.3 0.55 
Female, n (%) 10 (55.6) 9 (47.4) 0.64 
Aortic Atresia, n (%) 5 (31.3) 4 (23.5) 0.64 
TMS 10.1±0.9 9.8±1.0 0.34 
Pre-operative SaO2, % 90.1±4.0 89.9±6.1 0.57 
StO2, % 44.3±13.4 54.3±11.3 0.09# 
BFI, 10-8 cm2/s  3.0±1.9 1.9±1.1 0.05# 
CBV, mL/100g 2.1±0.6 2.1±0.4 0.52 
CMRO2,I, 10-7 ml/dl × cm2/s  2.1±2.0 1.2±0.7 0.13 
CPB time,  96.8±33.0 87.7±14.5 0.70 
DHCA time, min 46.4±12.0 43.3±6.7 0.74 
Lowest NP temperature,  17.9±1.0 17.6±0.8 0.20 
Number of bypass runs, n  1.2±0.5 1.0±0 0.14 
Delayed sternal closure, n (%) 4 (22.2) 1 (5.3) 0.14 
Cardiac arrest, n (%) 1 (5.6) 1 (0) 0.33 
Initial StO2, % 41.3±7.6 40.4±7.1 0.57 
Initial BFI, 10-8 cm2/s 1.6±0.9 1.3±0.3 0.35 
Initial CBV, mL/100g 3.9±0.7 3.8±0.8 0.83 
Initial CMRO2,i, 10-7 ml/dl × cm2/s  1.5±1.1 1.3±1.6 0.24 
Lowest StO2, % 34.2±10.5 35.9±8.3 0.65 
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Furthermore, multivariate logistic regression was performed to evaluate the 
significance of the explanatory variables to predict the likelihood of developing a large 
amount (i.e., greater than the median value) of new or worsened post-operative PVL.  
The final selected model was determined by stepwise selection, which is a combination 
of backward elimination and forward selections. In stepwise selection, an attempt is made 
to remove any insignificant variables from the model before adding a significant variable 
to the model. Each addition or deletion of a variable to or from a model is a separate step 
and at each step a new model is fitted.  The selection criteria was p<0.1. All variables 
tested in the univariate analysis were included for consideration in the stepwise selection 
approach.  The model resulting from this stepwise selection revealed that the probability 
of acquiring a large amount of PVL was positively associated with time-to-surgery 
(p=0.005), use of delayed sternal closure (p=0.07) and pre-operative BFI (p=0.08) as 
described by the formula:  
Log odds of PVL= −5.8+ 0.9× days to surgery+   2.9× Delayed Sternal Closure +   0.8× pre-operative  BFI ∙ 
(
(6.1) 
This model predicts that when holding delayed sternal closure and pre-operative BFI 
fixed, a one day increase in waiting time will increase the odds of developing PVL by 
2.5. 
To further illustrate the relationship between time-to-surgery and the likelihood of 
acquired PVL, Figure 37 shows a boxplot of volume of new or worsened post-operative 
PVL for those patients going to surgery at day-of-life 4 or earlier and those going to 
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surgery at day of life 5 or later (p=0.0005). The cut-off of day-of-life 4 was chosen for 
this visualization, because it resulted in the most significant difference in volume of 
acquired PVL between groups born before or after the cut-off. However, a cutoff of day-
of-life 3 or 5 also resulted in a significant difference in volume of acquired PVL (p=0.005 
and 0.02 respectively). Though TMS was included in both the univariate and multivariate 
analysis, we did not find it to be a significant predictor of new or worsened post-operative 
PVL. 
 
Figure 37: Boxplot of new or worsened PVL.  This plot demonstrates the 
significant (p=0.0005) difference in volume of new or worsened post-operative PVL for 
those patients going to surgery at day of life 4 or earlier (N=21) and those going to 
surgery at day of life 5 (N=16) or later.  Boxplot demonstrating the significant 
(p=0.0005) difference in volume of new or worsened post-operative PVL for those 
patients going to surgery at day of life 4 or earlier (N=21) and those going to surgery at 
day of life 5 (N=16) or later.  Two outliers were removed to improve visualization.  One 
outlier was in the left group and had a PVL volume of 7577.7 mm3, and the other outlier 
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was in the right group and had a PVL volume of 4981.5 mm3.  These outliers were only 
removed from the figure but not from any statistical analysis. 
        Additionally, we investigated the cross-sectional relationship between day of 
life and pre-operative StO2. As seen in Figure 38, a significant and negative linear 
correlation (R2=0.15, p=0.05, slope=-2.3±1.2) was observed between time-to-surgery and 
pre-operative StO2.  
 
Figure 38: Pre-operative cerebral oxygenation as a function of time-to-surgery. A 
significant correlation exists between pre-operative StO2 and time-to-surgery.  The solid 
line represents the bet-fit line to the data (R2=0.15, p=0.05, slope=-2.3±1.2).  The grey 
ribbon denotes the 95% confidence interval for the mean StO2. The symbols represent 
whether or not the subject acquired a large amount of new or worsened post-operative 
PVL. 
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Discussion 
We focused our study on identifying risk factors for post-operative injury, 
because while patients with HLHS have relatively mild injury pre-operatively, they 
experience a high rate of new and worsened injury following Stage I palliation [70, 73].  
In this cohort the prevalence of any new or worsened PVL was greater than 70%.  
Because of this highly skewed distribution of PVL volumes, the volumes were 
dichotomized around the median value to yield ‘none/small’ volumes and ‘large’ 
volumes (more clinically significant).  Thus, large volumes of new or worsened post-
operative PVL occurred in 48.7%.  
The major new finding in this study is that acquired post-operative PVL in infants 
with HLHS was highly correlated (p=0.0003) with longer time between birth and 
palliative infant heart surgery (time-to-surgery). No clinical indications were identified 
that resulted in delay of surgery in the group with a large amount of new or worsened 
PVL.  Delays were due to scheduling or availability of the requested surgeon. The day of 
the week of the infants birth also played a large role in time-to-surgery. For instance, the 
n=7 subjects born on a Wednesday had an average time-to-surgery was of 5.1±1.6 days, 
whereas the n=10 subjects born on a Monday had an average time-to-surgery of 3.7±2.2 
days. 
One possible explanation for the significance of time-to-surgery on the 
development of post-operative PVL is the negative linear trend observed between pre-
operative StO2 and time-to-surgery (Figure 38), suggesting that desaturation is occurring 
from birth until surgery. The correlation of pre-operative StO2 with new and worsened 
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post-operative PVL and time-to-surgery suggest that non-invasive optical monitoring of 
StO2 during the pre-operative period could be useful in further understanding the timing 
and cause for PVL and has the potential to further decrease the risk for injury  
 
Figure 39: Pre-operative cerebral oxygenation as a function of pre-operative BFI.  A 
significant negative correlation exists between StO2 and BFI. The solid line represents the 
bet-fit line to the data (Right: R2=0.18, p=0.04, slope=-3.2±1.4).  The grey ribbon denotes 
the 95% confidence interval for the mean StO2. The symbols represent whether or not the 
subject acquired a large amount of new or worsened post-operative PVL. 
 
The finding that higher pre-operative BFI is associated with new or worsened 
post-operative PVL in both a univariate and multivariate analysis was surprising and is 
currently under further investigation. As seen in Figure 39, higher pre-operative BFI is 
associated with a lower pre-operative StO2 (R2=0.18, p=0.04, slope=-3.2±1.4, Figure 39), 
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suggesting that perhaps cerebral oxygen metabolism is actually increasing pre-
operatively in this cohort.  That is, this trend is possibly a result of an increasing need for 
oxygen delivery to meet higher metabolic demand. While this parameter has not been 
measured in healthy newborn infants, it is likely that CMRO2 increases as infants emerge 
from the dark, quiet and warm uterine environment into the bright and chaotic world.  In 
infants with severe forms of CHD, this increased oxygen demand may not be well 
matched with poor, and possibly falling, cerebral oxygen delivery. Although we do not 
observe higher pre-operative CMRO2,i in infants who waited a long timer for surgery, 
there exists evidence to suggest that these changes may not be present in the frontal 
cortex, which is the region probed by all of these measurements. The idea that the oxygen 
demand is not being met is supported by the observed correlation between higher pre-
operative OEF and BFI (Figure 40). Further investigation, including serial measurements 
of CBF, StO2, OEF, and CMRO2 from birth to surgery on individual patients with and 
without severe CHD, is now underway and is crucial for understanding the role of CBF in 
injury risk (see Section 6.4.4).   
It is important to note again that this optically measured BFI is dependent on the 
optical properties of the tissue, mostly the reduced scattering coefficient (𝜇!´), which, in 
turn, is susceptible to errors arising from the flexible probes used in this study.  As 
explained in Section 4.5, BFI correlated better with blood flow measured in the sagittal 
sinus by MRI when the reduced scattering coefficient was assumed to be the same for all 
subjects, i.e., instead of using the measured 𝜇!´ for each subject as was done here. We 
found that assuming a fixed value for 𝜇!´ for all subjects resulted in a pre-operative BFI 
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that is not significantly different between the groups with and without a large amount of 
post-operative PVL.  Because of this finding, we believe that further investigation, 
including more accurate measures of 𝜇!´ and serial measurements of BFI from birth to 
surgery on individual patients, is necessary. 
 
Figure 40: Pre-operative oxygen extraction fraction as a function of time-to-surgery 
(left) and pre-operative BFI (right). The solid line represents the best-fit line to the data 
(Left: R2=0.16, p=0.04, slope=0.02±0.01; Right: R2=0.16, p=0.05, slope=0.03±0.01).  
The grey ribbon denotes the 95% confidence interval for the mean OEF. The symbols 
represent whether or not the subject acquired a large amount of new or worsened post-
operative PVL. 
 
In investigations of mixed populations of CHD infants who had early heart 
surgery with and without DHCA, both the use and total duration of DHCA were found to 
be a significant risk factor for the development of new post-operative PVL [9]. In the 
present study, where all patients had HLHS and received DHCA, duration of DHCA was 
not associated with increased PVL risk.  
Operative variables were assessed as risk factors for new or worsened PVL, but 
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the only variable that rose to significance in the multivariate analysis was whether the 
sternum was closed primarily or left open due to hemodynamic instability in the 
immediate post-operative observation period.  In the single ventricle reconstruction 
(SVR) trial, infants who were left with an open sternum post-operatively were at 
increased risk for both mortality and morbidity [81]. This finding held for both elective 
delayed sternal closure and for centers where the sternum was routinely left open as part 
of planned post-operative care.  The SVR trial did not evaluate post-operative brain 
MRIs, so there is no known prior association with white matter injury. However in Beca 
et al., new postoperative PVL was associated with a higher risk for death after discharge 
[9]. 
Previous studies in mixed populations have reported that delayed brain maturation 
quantified is a risk factor for PVL [9, 67]. In this study, we did not find TMS to be a 
significant predictor of new or worsened post-operative injury in our homogeneous 
cohort. However, patients with single ventricle physiology have, in general, a lower 
average brain maturation than other CHD [67] and, as a group, have the highest risk for 
PVL. Therefore, the association between brain maturation and PVL risk could easily be 
missed in this report.  Other patient characteristics such as gender and HLHS subtype (i.e. 
aortic atresia or aortic stenosis), which have previously been shown to be significant 
predictors of pre-operative PVL [73], were not significant predictors of acquired post-
operative injury in this cohort.  
The main limitation for this study is that pre-operative cerebral hemodynamics 
were only measured on the morning of surgery.  Thus all temporal data on time-to-
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surgery is cross-sectional.  To understand the mechanism behind the result that time-to-
surgery significantly predicts new or worsened post-operative PVL, longitudinal 
measures of CBF and StO2 from birth until surgery are needed. Additionally, the results 
reported herein are from a single center; these findings should be confirmed at other 
centers that manage patients with different operative strategies. However, the high 
statistical significance of the predictability of new or worsened post-operative PVL by 
time-to-surgery reported herein strongly suggests that decreasing the time to cardiac 
surgery in neonates with HLHS will decrease the probability of new or worsened post-
operative PVL. Since time-to-surgery was largely based on surgeon availability and what 
day of the week the patient was born on, we find this data provides sufficient justification 
for modifying the operative scheduling of these patients. 
 
6.4.3 Differences between HLHS and TGA: Revisited 
The results described in the previous section are compelling, because, as stated 
earlier, time-to-surgery was previously found to be predictive of pre-operative PVL in 
infants with TGA [10].  To begin to understand why time-to-surgery is predictive of PVL 
in both TGA and HLHS we took a closer look at the pre-operative cerebral 
hemodynamics presented in Section 6.4.1.  Figure 41 shows pre-operative BFI, StO2, 
OEF, and CMRO2,I for infants with HLHS and TGA who go to surgery on day-of-life 3 
and earlier and who go to surgery on day-of-life 4 or later.  As can be seen in Figure 41b, 
infants with both HLHS and TGA who wait longer for surgery have significantly lower 
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StO2.  Related to this is the result shown in Figure 41c, which shows that infants with 
both HLHS and TGA who wait longer for surgery have significantly higher OEF. 
 
Figure 41: Boxplots of pre-operative BFI for infants with HLHS and TGA who went to 
surgery earlier or later than day-of-life 4. Pre-operative variables are BFI (a) StO2 (b), 
OEF (c), CMRO2,i (d).  Each diagnosis is separated into two groups, for patients going to 
surgery on day of life 3 or early and patients going to surgery on day of life 4 or later. 
The red line denotes the median value; the blue square extends to the 25th and 75th 
percentiles; the whiskers extend to the most extreme data points that are not outliers; and 
the outliers are plotted as individual points.  All significant p-values calculated from a 
Wilcoxon rank-sum test are shown. 
 
These results begin to hint at a mechanism behind the importance of time-to-
surgery in the development of PVL in both cohorts of CHD patients.  Additionally, these 
results support the finding from Section 6.4.2 and suggest that earlier surgery is as 
important for prevention of brain injury in infants with HLHS as it is in infants with 
TGA. Our original hypothesis that the post-operative time period is important in 
 102 
predicting the development of PVL is now less supported.  Because of these novel results 
I have just reported, we shifted our focus to the pre-operative time period.  In section 
6.4.4, I discuss my most recent work which begins this in-depth investigation into the 
pre-operative time period. 
6.4.4 Serial pre-operative measurements 
As previously stated, the results reported thus far in this section are from a 
protocol in which we only acquire DOS/DCS data on a patient on the day of their 
surgery.  Thus, all trends with time-to-surgery are a cross-sectional look of our cohort.  
To fully understand the changes that are occurring as these patients are waiting for their 
surgery, we need to follow individual patients from birth until surgery. 
My most recent work investigates longitudinal measurements of pre-operative 
cerebral hemodynamics on individual patients.  Optical measurements, identical to the 
preoperative optical measurements performed on the morning of surgery and described in 
Section  6.2.2, were performed daily from birth until the morning of surgery.  A total of 
N=16 patients with either HLHS (N=6) or TGA (N=10) have been studied so far.  Figure 
42 shows these daily measurements of StO2 for the subjects with HLHS (left) and TGA 
(right).  These plots suggest a negative trend in StO2, however to quantify this, a linear 
regression was performed on each patient’s data to quantify a slope.  Although we have 
not yet recruited enough subjects to perform a meaningful multivariate analysis on these 
slopes, the results are promising.  Of the 6 subjects with HLHS, 4 had a negative trend of 
StO2 with age.  The 2 subjects that did not exhibit a negative trend had the shortest times-
to-surgery (2 and 3 days).  For infants with TGA, the trends of StO2 with age are even 
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more varied, however we observe a negative trend in the majority of patients studied so 
far.  Further patients with perhaps more frequent measurements will be necessary to  
perform further statistical analysis on this data. 
 
Figure 42: Daily measurements of StO2 from birth until surgery in N=6 subjects with 
HLHS (left) and N=10 subjects with TGA (right). 
 
Figure 43: Daily measurements of BFI from birth until surgery in N=6 subjects with 
HLHS (left) and N=10 subjects with TGA (right). 
Daily measurements of BFI were also acquired (Figure 43).  We see a negative 
slope in linear fits of BFI versus age for all infants with HLHS and a majority (N=6/7) 
infants with TGA, however more subjects must be recruited before conclusions on the 
trends of cerebral hemodynamics with waiting time to surgery can be drawn. 
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6.5 Conclusion 
I have studied pre- and post-operative cerebral oxygenation and blood flow in 
N=95 infants with critical congenital heart disease.  I have focused my efforts to 
understanding risk factors for pre- and post-operative PVL in infants with hypoplastic left 
heart syndrome and transposition of the great arteries.  I found that the prevalence of PVL 
is greater in infants with HLHS than with TGA, and that the majority of PVL seen in this 
cohort is observed on post-operative MRI scans.  Specifically, we observed a large 
amount of new or worsened post-operative PVL in 48.7% (18/37) of patients in our 
cohort. 
The main result reported herein is from the investigation of risk factors for acquired 
post-operative PVL in neonates with HLHS. The risk for injury in this population 
significantly increases with longer time to surgical repair.  Additionally, a significant 
correlation exists between time-to-surgery and cerebral oxygen saturation, suggesting that 
changes in cerebral oxygen metabolism are occurring between birth and surgical repair 
and may be at the core to this increase risk for injury.   
Comparisons of infants with HLHS and TGA show that both groups have higher 
cerebral oxygen extraction fractions and lower cerebral tissue oxygen saturation 
associated with longer time-to-surgery.  The results suggest that correcting the native, 
abnormal vascular anatomy as soon as possible in both of these cohorts may be the most 
important factor in mitigating brain injury. 
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7 Conclusions and Future Directions 
Over the past decade, research in the field of congenital heart disease has focused 
on improvements of neurodevelopmental outcomes.  With the now understood high 
prevalence of brain injury in the form of periventricular leukomalacia (PVL) that exists in 
these children, current efforts aim to identify risk factors for this quantifiable injury 
Diffuse optical spectroscopies enable monitoring of highly relevant physiological 
parameters in this patient population, namely cerebral blood oxygenation and blood flow.  
In this thesis, I described the use of these techniques for the investigation of risk factors 
for PVL, among other studies.   
The most important result from this dissertation concerns risk factors for new or 
worsened post-operative PVL in infants with hypoplastic left heart syndrome.  
Specifically, my work has shown that longer time-to-surgery, lower pre-operative 
cerebral oxygenation, and higher pre-operative cerebral blood flow, measured with 
diffuse optics, are associated with occurrence of new post-operative PVL and increases in 
post-operative PVL from pre-operative levels.  This novel result paves the way for further 
exploration into the exact reasoning behind this association as well as possible prevention 
strategies in hospitals and situations when earlier surgery is not possible. Because of 
these results, the focus of research at CHOP has now shifted to concentrating on the pre-
operative time period in infants with CHD. The future direction of the studies reported 
herein is to employ diffuse optical spectroscopy and diffuse correlation spectroscopy to 
monitor cerebral hemodynamics from birth until surgery in infants with congenital heart 
disease.  Additionally, the effect of time-to-surgery on the risk for PVL needs to be 
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investigated in infants with other forms of CHDs, since currently this has only been 
shown in HLHS and TGA.  The ultimate goals will be to pinpoint the ideal time for 
surgery and optimal values for cerebral oxygenation and blood flow to avoid PVL in all 
forms of CHD. 
DOS and DCS are uniquely suited for pediatrics and especially for neonatal brain 
monitoring.  Practically speaking, the relative thinness of the neonatal skull and scalp 
allows for deeper penetration of brain tissue. While this technology, especially DCS, has 
improved and expanded significantly over the past decade, there are several roadblocks 
that need to be overcome before DCS can be fully and widely integrated into a clinical 
setting.  While DCS has been extensively shown to provide an accurate measurement of 
changes in CBF, validation of absolute blood flow has been carried out in limited 
populations and, in general, is less robust.  Calibrating DCS measures to estimate 
absolute values of blood flow will depend on the accurate measurements of 𝜇!′.  
Improvement of this measurement, in turn, will depend on understanding the partial 
volume effects of the DOS measurements, accuracy in the source-detector separation, and 
improvements on the assumption of geometry.  
In addition to improving the measurements of BFI, a user-friendly interface needs 
to be developed to give clinicians the ability to use these instruments with ease.  
Similarly, the patient interface needs to be improved. All of the work presented in this 
thesis was from measurements made only on the frontal cortex.  Improvements in 
instrumentation need to be made to allow for more source-detector pairs and thus more 
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coverage of the brain.  To do this, issues like interaction of hair follicles need to be 
addressed. 
Despite these current roadblocks, I believe that diffuse optics will play a critical 
role in the clinical care of pediatric patients in the years to come.  DOS and DCS will 
continue to be used in research for understanding the complex changes in cerebral 
physiology that are occurring after birth.  Beyond its already impressive role in research, 
I believe that hybrid DOS/DCS devices will be commercialized and become part of 
clinical care.  I envision these optical techniques will be used to individualize care and 
gather information about cerebral hemodynamics in real time.  For instance, if two infant 
with CHD are born on the same day and one must be operated on first, optical monitoring 
of cerebral hemodynamics could lend insight into which patient is more at risk for 
acquiring injury and thus help clinicians make these difficult decisions. 
In addition to infants with CHD, DOS and DCS will be a valuable tool in a 
multitude of pediatric, as well as adult, patient populations.  Examples include 
understanding the relationship between healthy electroencephalography (EEG) signals 
during seizures with cerebral hemodynamics in different regions of the brain, which will 
provide clinicians valuable insight into the effects of these seizures on cerebral 
vasculature.  I believe that within the next 20 years, hybrid DOS/DCS instruments will be 
part of clinical care and used for individual monitoring of patients cerebral 
hemodynamics at the bedside for individualizing patient care.  
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